{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:02:01Z","timestamp":1792555321784,"version":"4.5.0"},"reference-count":273,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["Core Research Grant; Grant Number: CRG\/2021\/001009)"],"award-info":[{"award-number":["Core Research Grant; Grant Number: CRG\/2021\/001009)"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00210-023-02939-y","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T21:03:14Z","timestamp":1705352594000},"page":"3867-3895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders"],"prefix":"10.1007","volume":"397","author":[{"given":"Aditi","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuber","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acharan S","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reni","family":"Kalfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"issue":"3","key":"2939_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12031-019-01425-6","volume":"70","author":"HA Abo Taleb","year":"2020","unstructured":"Abo Taleb HA, Alghamdi BS (2020) Neuroprotective effects of melatonin during demyelination and remyelination stages in a mouse model of multiple sclerosis. J Mol Neurosci MN 70(3):386\u2013402. https:\/\/doi.org\/10.1007\/s12031-019-01425-6","journal-title":"J Mol Neurosci MN"},{"issue":"1","key":"2939_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4103\/jfmpc.jfmpc_1839_21","volume":"11","author":"WA Al Twaijri","year":"2022","unstructured":"Al Twaijri WA, Ba Armah D, Bin Sabbar N, Aldebasi T, Shaheen N, Al Bekairy AKS, Al-Jeraisy M (2022) Effect of melatonin in children with neurodevelopmental disabilities and sleep disorders. J Family Med Prim Care 11(1):299\u2013304. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1839_21","journal-title":"J Family Med Prim Care"},{"key":"2939_CR3","doi-asserted-by":"publisher","first-page":"105839","DOI":"10.1016\/j.phrs.2021.105839","volume":"173","author":"AF Alamdari","year":"2021","unstructured":"Alamdari AF, Rahnemayan S, Rajabi H, Vahed N, Kashani HRK, Rezabakhsh A, Sanaie S (2021) Melatonin as a promising modulator of aging related neurodegenerative disorders: role of microRNAs. Pharmacol Res 173:105839. https:\/\/doi.org\/10.1016\/j.phrs.2021.105839","journal-title":"Pharmacol Res"},{"issue":"11","key":"2939_CR4","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/biomedicines10112866","volume":"10","author":"TH Albekairi","year":"2022","unstructured":"Albekairi TH, Kamra A, Bhardwaj S, Mehan S, Giri A, Suri M, Alshammari A, Alharbi M, Alasmari AF, Narula AS, Kalfin R (2022) Beta-boswellic acid reverses 3-nitropropionic acid-induced molecular, mitochondrial, and histopathological defects in experimental rat model of Huntington\u2019s disease. Biomedicines 10(11):2866. https:\/\/doi.org\/10.3390\/biomedicines10112866","journal-title":"Biomedicines"},{"issue":"7","key":"2939_CR5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/jnr.24220","volume":"96","author":"BS Alghamdi","year":"2018","unstructured":"Alghamdi BS (2018) The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 96(7):1136\u20131149. https:\/\/doi.org\/10.1002\/jnr.24220","journal-title":"J Neurosci Res"},{"issue":"2","key":"2939_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.31083\/j.jin.2020.02.32","volume":"19","author":"BS Alghamdi","year":"2020","unstructured":"Alghamdi BS, AboTaleb HA (2020) Melatonin improves memory defects in a mouse model of multiple sclerosis by up-regulating cAMP-response element-binding protein and synapse-associated proteins in the prefrontal cortex. J Integr Neurosci 19(2):229\u2013237","journal-title":"J Integr Neurosci"},{"issue":"22","key":"2939_CR7","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.3390\/molecules27227951","volume":"27","author":"M Alharbi","year":"2022","unstructured":"Alharbi M, Alshammari A, Kaur G, Kalra S, Mehan S, Suri M, Chhabra S, Kumar N, Alanazi WA, Alshanwani AR, Al-Ghamdi AH, Narula AS, Kalfin R (2022) Effect of natural ADENYLCYCLASE\/CAMP\/CREB signalling activator forskolin against intra-striatal 6-OHDA-lesioned parkinson\u2019s rats: preventing mitochondrial, motor and histopathological defects. Molecules (Basel, Switzerland) 27(22):7951. https:\/\/doi.org\/10.3390\/molecules27227951","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"2939_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jpi.12238","volume":"59","author":"T Ali","year":"2015","unstructured":"Ali T, Kim MO (2015) Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3\/Akt\/GSk3\u03b2 pathway in the mouse hippocampus. J Pineal Res 59(1):47\u201359. https:\/\/doi.org\/10.1111\/jpi.12238","journal-title":"J Pineal Res"},{"issue":"1","key":"2939_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jpi.12194","volume":"58","author":"T Ali","year":"2014","unstructured":"Ali T, Badshah H, Kim TH, Kim MO (2014) Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE\/NF-KB\/JNK signaling pathway in aging mouse model. J Pineal Res 58(1):71\u201385. https:\/\/doi.org\/10.1111\/jpi.12194","journal-title":"J Pineal Res"},{"issue":"2","key":"2939_CR10","doi-asserted-by":"publisher","first-page":"e12667","DOI":"10.1111\/jpi.12667","volume":"69","author":"T Ali","year":"2020","unstructured":"Ali T, Rahman SU, Hao Q, Li W, Liu Z, Ali Shah F, Murtaza I, Zhang Z, Yang X, Liu G, Li S (2020) Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation. J Pineal Res 69(2):e12667. https:\/\/doi.org\/10.1111\/jpi.12667","journal-title":"J Pineal Res"},{"key":"2939_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fimmu.2016.00278","volume":"7","author":"Z Al-Jaderi","year":"2016","unstructured":"Al-Jaderi Z, Maghazachi AA (2016) Utilization of dimethyl fumarate and related molecules for treatment of multiple sclerosis, cancer, and other diseases. Front Immunol 7:278. https:\/\/doi.org\/10.3389\/fimmu.2016.00278","journal-title":"Front Immunol"},{"issue":"1","key":"2939_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","volume":"96","author":"DG Allen","year":"2016","unstructured":"Allen DG, Whitehead NP, Froehner SC (2016) Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev 96(1):253\u2013305. https:\/\/doi.org\/10.1152\/physrev.00007.2015","journal-title":"Physiol Rev"},{"issue":"4","key":"2939_CR13","doi-asserted-by":"publisher","first-page":"e12442","DOI":"10.1111\/jpi.12442","volume":"63","author":"N \u00c1lvarez-S\u00e1nchez","year":"2017","unstructured":"\u00c1lvarez-S\u00e1nchez N, Cruz-Chamorro I, D\u00edaz-S\u00e1nchez M, Sarmiento-Soto H, Medrano-Campillo P, Mart\u00ednez-L\u00f3pez A, Carrillo-Vico A (2017) Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients. J Pineal Res 63(4):e12442. https:\/\/doi.org\/10.1111\/jpi.12442","journal-title":"J Pineal Res"},{"key":"2939_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/17446651.2019.1631158","volume":"14","author":"FGD Amaral","year":"2019","unstructured":"Amaral FGD, Andrade-Silva J, Kuwabara WMT, Cipolla-Neto J (2019) New insights into the function of melatonin and its role in metabolic disturbances. Expert Rev Endocrinol Metab 14:293\u2013300. https:\/\/doi.org\/10.1080\/17446651.2019.1631158","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"7","key":"2939_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/aas.12747","volume":"60","author":"LP Andersen","year":"2016","unstructured":"Andersen LP (2016) The analgesic effects of exogenous melatonin in humans. Acta Anaesthesiol Scand 60(7):1024\u20131025. https:\/\/doi.org\/10.1111\/aas.12747","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"2939_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11011-012-9307-9","volume":"27","author":"G Anderson","year":"2012","unstructured":"Anderson G, Maes M (2012) Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metab Brain Dis 27(2):113\u2013119. https:\/\/doi.org\/10.1007\/s11011-012-9307-9","journal-title":"Metab Brain Dis"},{"issue":"7","key":"2939_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1096\/fj.03-1031fje","volume":"18","author":"SA Andrabi","year":"2004","unstructured":"Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TF (2004) Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB Journal\u202f: official publication of the Federation of American Societies for Experimental Biology 18(7):869\u2013871. https:\/\/doi.org\/10.1096\/fj.03-1031fje","journal-title":"FASEB Journal : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"5","key":"2939_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.arcmed.2019.08.005","volume":"50","author":"SS Andrabi","year":"2019","unstructured":"Andrabi SS, Vishnoi S, Kaushik M, Parveen K, Tabassum H, Akram M, Parvez S (2019) Reversal of schizophrenia-like symptoms and cholinergic alterations by melatonin. Arch Med Res 50(5):295\u2013303. https:\/\/doi.org\/10.1016\/j.arcmed.2019.08.005","journal-title":"Arch Med Res"},{"issue":"1\u20133","key":"2939_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2013.01.007","volume":"701","author":"E Antunes Wilhelm","year":"2013","unstructured":"Antunes Wilhelm E, Ricardo Jesse C, Folharini Bortolatto C, Wayne Nogueira C (2013) Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington\u2019s disease: protective effect of melatonin. Eur J Pharmacol 701(1\u20133):65\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.007","journal-title":"Eur J Pharmacol"},{"key":"2939_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fendo.2019.00391","volume":"10","author":"J Arendt","year":"2019","unstructured":"Arendt J (2019) Melatonin: countering chaotic time cues. Front Endocrinol 10:391. https:\/\/doi.org\/10.3389\/fendo.2019.00391","journal-title":"Front Endocrinol"},{"key":"2939_CR21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3389\/fimmu.2019.01511","volume":"10","author":"BI Arioz","year":"2019","unstructured":"Arioz BI, Tastan B, Tarakcioglu E, Tufekci KU, Olcum M, Ersoy N, Bagriyanik A, Genc K, Genc S (2019) Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1\/Nrf2 pathway. Front Immunol 10:1511. https:\/\/doi.org\/10.3389\/fimmu.2019.01511","journal-title":"Front Immunol"},{"issue":"7","key":"2939_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/antiox10071020","volume":"10","author":"BI Arioz","year":"2021","unstructured":"Arioz BI, Tarakcioglu E, Olcum M, Genc S (2021) The role of melatonin on NLRP3 inflammasome activation in diseases. Antioxidants (Basel, Switzerland) 10(7):1020. https:\/\/doi.org\/10.3390\/antiox10071020","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"3","key":"2939_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14715\/cmb\/2021.67.3.13","volume":"67","author":"Z Asefy","year":"2021","unstructured":"Asefy Z, Khusro A, Mammadova S, Hoseinnejhad S, Eftekhari A, Alghamdi S, Dablool AS, Almehmadi M, Kazemi E, Sahibzada MUK (2021) Melatonin hormone as a therapeutic weapon against neurodegenerative diseases. cellular and molecular biology (noisy-le-grand, France). Cell Mol Biol (Noisy-le-Grand, France) 67(3):99\u2013106","journal-title":"Cell Mol Biol (Noisy-le-Grand, France)"},{"key":"2939_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","volume":"34","author":"F Auld","year":"2017","unstructured":"Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL (2017) Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev 34:10\u201322. https:\/\/doi.org\/10.1016\/j.smrv.2016.06.005","journal-title":"Sleep Med Rev"},{"issue":"2","key":"2939_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00406-016-0711-8","volume":"267","author":"L Baandrup","year":"2017","unstructured":"Baandrup L, Fagerlund B, Glenthoj B (2017) Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo. Eur Arch Psychiatry Clin Nneurosci 267(2):163\u2013171. https:\/\/doi.org\/10.1007\/s00406-016-0711-8","journal-title":"Eur Arch Psychiatry Clin Nneurosci"},{"issue":"4","key":"2939_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/mus.27168","volume":"63","author":"EM Bald","year":"2021","unstructured":"Bald EM, Nance CS, Schultz JL (2021) Melatonin may slow disease progression in amyotrophic lateral sclerosis: findings from the pooled resource open-access ALS clinic trials database. Muscle Nerve. 63(4):572\u2013576. https:\/\/doi.org\/10.1002\/mus.27168","journal-title":"Muscle Nerve."},{"issue":"3","key":"2939_CR27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/antiox11030532","volume":"11","author":"M Bantounou","year":"2022","unstructured":"Bantounou M, Plascevic J, Galley HF (2022) Melatonin and related compounds: antioxidant and anti-inflammatory actions. Antioxidants (Basel, Switzerland) 11(3):532. https:\/\/doi.org\/10.3390\/antiox11030532","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"2939_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","volume":"1593","author":"TB Bassani","year":"2014","unstructured":"Bassani TB, Gradowski RW, Zaminelli T, Barbiero JK, Santiago RM, Boschen SL, da Cunha C, Lima MM, Andreatini R, Vital MA (2014) Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced parkinson\u2019s disease model in rats. Brain Res 1593:95\u2013105. https:\/\/doi.org\/10.1016\/j.brainres.2014.09.068","journal-title":"Brain Res"},{"key":"2939_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.physbeh.2015.06.040","volume":"151","author":"M Bazrgar","year":"2015","unstructured":"Bazrgar M, Goudarzi I, Lashkarbolouki T, Elahdadi Salmani M (2015) Melatonin ameliorates oxidative damage induced by maternal lead exposure in rat pups. Physiol Beh 151:178\u2013188. https:\/\/doi.org\/10.1016\/j.physbeh.2015.06.040","journal-title":"Physiol Beh"},{"issue":"1","key":"2939_CR30","doi-asserted-by":"publisher","first-page":"17746","DOI":"10.1038\/s41598-017-18016-3","volume":"7","author":"M Benabou","year":"2017","unstructured":"Benabou M, Rolland T, Leblond CS, Millot GA, Huguet G, Delorme R, Leboyer M, Pagan C, Callebert J, Maronde E, Bourgeron T (2017) Heritability of the melatonin synthesis variability in autism spectrum disorders. Sci Rep 7(1):17746. https:\/\/doi.org\/10.1038\/s41598-017-18016-3","journal-title":"Sci Rep"},{"issue":"6","key":"2939_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/00207454.2017.1398156","volume":"128","author":"I Berkiks","year":"2017","unstructured":"Berkiks I, Benmhammed H, Mesfioui A, Ouichou A, ElHasnaoui A, Mouden S, ElHessni A (2017) Postnatal melatonin treatment protects against affective disorders induced by early-life immune stimulation by reducing the microglia cell activation and oxidative stress. Int J Neurosci 128(6):495\u2013504. https:\/\/doi.org\/10.1080\/00207454.2017.1398156","journal-title":"Int J Neurosci"},{"key":"2939_CR32","doi-asserted-by":"publisher","first-page":"102296","DOI":"10.1016\/j.npep.2022.102296","volume":"96","author":"S Bhalla","year":"2022","unstructured":"Bhalla S, Mehan S (2022) 4-hydroxyisoleucine mediated IGF-1\/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats. Neuropeptides 96:102296. https:\/\/doi.org\/10.1016\/j.npep.2022.102296","journal-title":"Neuropeptides"},{"issue":"1","key":"2939_CR33","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1038\/s41598-020-63986-6","volume":"10","author":"SS Bidabadi","year":"2020","unstructured":"Bidabadi SS, VanderWeide J, Sabbatini P (2020) Exogenous melatonin improves glutathione content, redox state and increases essential oil production in two salvia species under drought stress. Sci Rep 10(1):6883. https:\/\/doi.org\/10.1038\/s41598-020-63986-6","journal-title":"Sci Rep"},{"issue":"1","key":"2939_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1556\/2060.105.2018.1.1","volume":"105","author":"I Bin-Jaliah","year":"2018","unstructured":"Bin-Jaliah I, Sakr HF (2018) Melatonin ameliorates brain oxidative stress and upregulates senescence marker protein-30 and osteopontin in a rat model of vascular dementia. Physiol Int 105(1):38\u201352. https:\/\/doi.org\/10.1556\/2060.105.2018.1.1","journal-title":"Physiol Int"},{"issue":"8","key":"2939_CR35","doi-asserted-by":"publisher","first-page":"105864","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105864","volume":"30","author":"SC Bir","year":"2021","unstructured":"Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE (2021) Emerging concepts in vascular dementia: a review. J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc 30(8):105864. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105864","journal-title":"J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc"},{"key":"2939_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.parkreldis.2016.05.012","volume":"29","author":"DP Breen","year":"2016","unstructured":"Breen DP, Barker RA (2016) Exogenous melatonin for parkinson\u2019s disease: \u2018waking up\u2019 to the need for further trials. Parkinsonism Relate Disord 29:121\u2013122. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.05.012","journal-title":"Parkinsonism Relate Disord"},{"key":"2939_CR37","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1080\/14656566.2019.1674283","volume":"20","author":"O Bruni","year":"2019","unstructured":"Bruni O, Angriman M, Melegari MG, Ferri R (2019) Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opin Pharmacother 20:2257\u20132271. https:\/\/doi.org\/10.1080\/14656566.2019.1674283","journal-title":"Expert Opin Pharmacother"},{"key":"2939_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.comppsych.2016.03.005","volume":"68","author":"JM Bumb","year":"2016","unstructured":"Bumb JM, Enning F, Mueller JK, van der List T, Rohleder C, Findeisen P, Noelte I, Schwarz E, Leweke FM (2016) Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder. Comprehen Psychiatry 68:34\u201339. https:\/\/doi.org\/10.1016\/j.comppsych.2016.03.005","journal-title":"Comprehen Psychiatry"},{"issue":"4","key":"2939_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1600-079X.2011.00962.x","volume":"52","author":"DP Cardinali","year":"2012","unstructured":"Cardinali DP, Srinivasan V, Brzezinski A, Brown GM (2012) Melatonin and its analogs in insomnia and depression. J Pineal Res 52(4):365\u2013375. https:\/\/doi.org\/10.1111\/j.1600-079X.2011.00962.x","journal-title":"J Pineal Res"},{"key":"2939_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2018.08.018","volume":"204","author":"G Carr\u00e0","year":"2019","unstructured":"Carr\u00e0 G, Crocamo C, Angermeyer M, Brugha T, Toumi M, Bebbington P (2019) Positive and negative symptoms in schizophrenia: a longitudinal analysis using latent variable structural equation modelling. Schizophrenia Res 204:58\u201364","journal-title":"Schizophrenia Res"},{"key":"2939_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainres.2015.12.03","volume":"1633","author":"CH Carriere","year":"2016","unstructured":"Carriere CH, Kang NH, Niles LP (2016) Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of parkinson\u2019s disease. Brain Res 1633:115\u2013125. https:\/\/doi.org\/10.1016\/j.brainres.2015.12.03","journal-title":"Brain Res"},{"issue":"6","key":"2939_CR42","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1096\/fj.14-265678","volume":"29","author":"E Cecon","year":"2015","unstructured":"Cecon E, Chen M, Mar\u00e7ola M, Fernandes PA, Jockers R, Markus RP (2015) Amyloid \u03b2 peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway. FASEB J Off Public Federation Am Soc Exp Biol 29(6):2566\u20132582. https:\/\/doi.org\/10.1096\/fj.14-265678","journal-title":"FASEB J Off Public Federation Am Soc Exp Biol"},{"issue":"1","key":"2939_CR43","first-page":"75","volume":"65","author":"K Celinski","year":"2014","unstructured":"Celinski K, Konturek PC, Slomka M, Cichoz-Lach H, Brzozowski T, Konturek SJ, Korolczuk A (2014) Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease\u201314 months follow up. J Physiol Pharmacol Off J Polish Physiol Soc 65(1):75\u201382","journal-title":"J Physiol Pharmacol Off J Polish Physiol Soc"},{"issue":"7","key":"2939_CR44","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/ijms18071439","volume":"18","author":"MG Cerc\u00f3s","year":"2017","unstructured":"Cerc\u00f3s MG, Galv\u00e1n-Arrieta T, Vald\u00e9s-Tovar M, Sol\u00eds-Chagoy\u00e1n H, Argueta J, Ben\u00edtez-King G, Trueta C (2017) Abnormally increased secretion in olfactory neuronal precursors from a case of schizophrenia is modulated by melatonin: a pilot study. Int J Mol Sci 18(7):1439. https:\/\/doi.org\/10.3390\/ijms18071439","journal-title":"Int J Mol Sci"},{"key":"2939_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbr.2014.01.048","volume":"264","author":"J Chakraborty","year":"2014","unstructured":"Chakraborty J, Nthenge-Ngumbau DN, Rajamma U, Mohanakumar KP (2014) Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. Behav Brain Res 264:91\u2013104. https:\/\/doi.org\/10.1016\/j.bbr.2014.01.048","journal-title":"Behav Brain Res"},{"issue":"3","key":"2939_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1600-079X.2011.00945.x","volume":"52","author":"CF Chang","year":"2012","unstructured":"Chang CF, Huang HJ, Lee HC, Hung KC, Wu RT, Lin AM (2012) Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and \u03b1-synuclein aggregation. J Pineal Res 52(3):312\u2013321. https:\/\/doi.org\/10.1111\/j.1600-079X.2011.00945.x","journal-title":"J Pineal Res"},{"issue":"10","key":"2939_CR47","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.3390\/ijms22105343","volume":"22","author":"CY Chang","year":"2021","unstructured":"Chang CY, Luo DZ, Pei JC, Kuo MC, Hsieh YC, Lai WS (2021) Not just a bystander: the emerging role of astrocytes and research tools in studying cognitive dysfunctions in schizophrenia. Int J Mol Sci 22(10):5343. https:\/\/doi.org\/10.3390\/ijms22105343","journal-title":"Int J Mol Sci"},{"issue":"2\u20133","key":"2939_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10974-020-09578-3","volume":"41","author":"B Chen","year":"2020","unstructured":"Chen B, You W, Shan T (2020) The regulatory role of melatonin in skeletal muscle. J Muscle Res Cell Motil 41(2\u20133):191\u2013198. https:\/\/doi.org\/10.1007\/s10974-020-09578-3","journal-title":"J Muscle Res Cell Motil"},{"issue":"8","key":"2939_CR49","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/biom10081158","volume":"10","author":"D Chen","year":"2020","unstructured":"Chen D, Zhang T, Lee TH (2020) Cellular mechanisms of melatonin: insight from neurodegenerative diseases. Biomolecules 10(8):1158. https:\/\/doi.org\/10.3390\/biom10081158","journal-title":"Biomolecules"},{"issue":"18","key":"2939_CR50","doi-asserted-by":"publisher","first-page":"10402","DOI":"10.1111\/jcmm.15654","volume":"24","author":"KH Chen","year":"2020","unstructured":"Chen KH, Lin KC, Ko SF, Chiang JY, Guo J, Yip HK (2020) Melatonin against acute ischaemic stroke dependently via suppressing both inflammatory and oxidative stress downstream signallings. J Cell Mol Med 24(18):10402\u201310419. https:\/\/doi.org\/10.1111\/jcmm.15654","journal-title":"J Cell Mol Med"},{"key":"2939_CR51","doi-asserted-by":"publisher","first-page":"578200","DOI":"10.1016\/j.jneuroim.2023.578200","volume":"384","author":"S Chhabra","year":"2023","unstructured":"Chhabra S, Mehan S, Khan Z, Gupta GD, Narula AS (2023) Matrine mediated neuroprotective potential in experimental multiple sclerosis: evidence from CSF, blood markers, brain samples and in-silico investigations. J Neuroimmunol 384:578200. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578200. (Advance online publication)","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2939_CR52","doi-asserted-by":"publisher","first-page":"e12470","DOI":"10.1111\/jpi.12470","volume":"64","author":"V Chinchalongporn","year":"2018","unstructured":"Chinchalongporn V, Shukla M, Govitrapong P (2018) Melatonin ameliorates A\u03b242 -induced alteration of \u03b2APP-processing secretases via the melatonin receptor through the Pin1\/GSK3\u03b2\/NF-\u03baB pathway in SH-SY5Y cells. J Pineal Res 64(4):e12470. https:\/\/doi.org\/10.1111\/jpi.12470","journal-title":"J Pineal Res"},{"issue":"9","key":"2939_CR53","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/biom10091211","volume":"10","author":"DM Chitimus","year":"2020","unstructured":"Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L, Zagrean AM (2020) Melatonin\u2019s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules 10(9):1211. https:\/\/doi.org\/10.3390\/biom10091211","journal-title":"Biomolecules"},{"key":"2939_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6842568","volume":"2016","author":"MH Choi","year":"2016","unstructured":"Choi MH, Ow JR, Yang N-D, Taneja R (2016) Oxidative stress-mediated skeletal muscle degeneration: molecules, mechanisms, and therapies. Oxid Med Cell Long 2016:1\u201313. https:\/\/doi.org\/10.1155\/2016\/6842568","journal-title":"Oxid Med Cell Long"},{"key":"2939_CR55","doi-asserted-by":"publisher","first-page":"1849794","DOI":"10.1155\/2018\/1849794","volume":"2018","author":"F Christidi","year":"2018","unstructured":"Christidi F, Migliaccio R, Santamar\u00eda-Garc\u00eda H, Santangelo G, Trojsi F (2018) Social cognition dysfunctions in neurodegenerative diseases: neuroanatomical correlates and clinical implications. Behav Neurol 2018:1849794. https:\/\/doi.org\/10.1155\/2018\/1849794","journal-title":"Behav Neurol"},{"key":"2939_CR56","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00084","author":"J Cipolla-Neto","year":"2018","unstructured":"Cipolla-Neto J, Do Amaral FG (2018) Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. https:\/\/doi.org\/10.1210\/er.2018-00084","journal-title":"Endocr Rev"},{"issue":"1","key":"2939_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1503\/jpn.130009","volume":"39","author":"S Comai","year":"2014","unstructured":"Comai S, Gobbi G (2014) Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci JPN 39(1):6\u201321. https:\/\/doi.org\/10.1503\/jpn.130009","journal-title":"J Psychiatry Neurosci JPN"},{"key":"2939_CR58","doi-asserted-by":"publisher","first-page":"e12515","DOI":"10.1111\/jpi.12515","volume":"65","author":"R Corpas","year":"2018","unstructured":"Corpas R, Gri\u00f1\u00e1n-Ferr\u00e9 C, Palomera-\u00c1valos V, Porquet D, Garc\u00eda de Frutos P, Franciscato Cozzolino SM, Cardoso BR (2018) Melatonin induces mechanisms of brain resilience against neurodegeneration. J Pineal Res 65:e12515. https:\/\/doi.org\/10.1111\/jpi.12515","journal-title":"J Pineal Res"},{"issue":"1","key":"2939_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","volume":"16","author":"J Cummings","year":"2021","unstructured":"Cummings J (2021) New approaches to symptomatic treatments for alzheimer\u2019s disease. Mol Neurodegener 16(1):2. https:\/\/doi.org\/10.1186\/s13024-021-00424-9","journal-title":"Mol Neurodegener"},{"issue":"1\u20132","key":"2939_CR60","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jns.2015.03.040","volume":"353","author":"A Damasceno","year":"2015","unstructured":"Damasceno A, Moraes AS, Farias A, Damasceno BP, dos Santos LMB, Cendes F (2015) Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: a preliminary study. J Neurol Sci 353(1\u20132):166\u2013168. https:\/\/doi.org\/10.1016\/j.jns.2015.03.040","journal-title":"J Neurol Sci"},{"key":"2939_CR61","doi-asserted-by":"publisher","first-page":"105878","DOI":"10.1016\/j.clineuro.2020.105878","volume":"195","author":"R Daneshvar Kakhaki","year":"2020","unstructured":"Daneshvar Kakhaki R, Ostadmohammadi V, Kouchaki E, Aghadavod E, Bahmani F, Tamtaji ORJ, Reiter R, Mansournia MA, Asemi Z (2020) Melatonin supplementation and the effects on clinical and metabolic status in parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Clin Neurol Neuro 195:105878. https:\/\/doi.org\/10.1016\/j.clineuro.2020.105878","journal-title":"Clin Neurol Neuro"},{"key":"2939_CR62","doi-asserted-by":"publisher","first-page":"175909142098120","DOI":"10.1177\/1759091420981204","volume":"12","author":"R Das","year":"2020","unstructured":"Das R, Balmik AA, Chinnathambi S (2020) Melatonin reduces GSK3\u03b2-mediated tau phosphorylation, enhances Nrf2 nuclear translocation and anti-inflammation. Am Soc Neurochem ASN Neuro 12:1759091420981204. https:\/\/doi.org\/10.1177\/1759091420981204","journal-title":"Am Soc Neurochem ASN Neuro"},{"key":"2939_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cophys.2019.12.015","volume":"15","author":"T Deboer","year":"2020","unstructured":"Deboer T (2020) Circadian regulation of sleep in mammals. Curr Opin Physiol 15:89\u201395. https:\/\/doi.org\/10.1016\/j.cophys.2019.12.015","journal-title":"Curr Opin Physiol"},{"key":"2939_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuint.2014.06.015","volume":"76","author":"K Ding","year":"2014","unstructured":"Ding K, Wang H, Xu J, Lu X, Zhang L, Zhu L (2014) Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: possible involvement of mTOR pathway. Neurochem Int 76:23\u201331. https:\/\/doi.org\/10.1016\/j.neuint.2014.06.015","journal-title":"Neurochem Int"},{"issue":"3","key":"2939_CR65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000489470","volume":"76","author":"M Dmitrzak-Weglarz","year":"2017","unstructured":"Dmitrzak-Weglarz M, Reszka E (2017) Pathophysiology of depression: molecular regulation of melatonin homeostasis\u2014current status. Neuropsychobiology 76(3):117\u2013129. https:\/\/doi.org\/10.1159\/000489470","journal-title":"Neuropsychobiology"},{"issue":"1","key":"2939_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Prime 7(1):13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3","journal-title":"Nat Rev Dis Prime"},{"issue":"1","key":"2939_CR67","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/adr-190125","volume":"3","author":"P Duggal","year":"2019","unstructured":"Duggal P, Mehan S (2019) Neuroprotective approach of anti-cancer microtubule stabilizers against tauopathy associated dementia: current status of clinical and preclinical findings. J Alzheimer\u2019s Dis Rep 3(1):179\u2013218. https:\/\/doi.org\/10.3233\/adr-190125","journal-title":"J Alzheimer\u2019s Dis Rep"},{"issue":"1\u20132","key":"2939_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jns.2014.10.009","volume":"347","author":"MA El-Missiry","year":"2014","unstructured":"El-Missiry MA, Othman AI, Al-Abdan MA, El-Sayed AA (2014) Melatonin ameliorates oxidative stress, modulates death receptor pathway proteins, and protects the rat cerebrum against bisphenol-a\u03b2-induced apoptosis. J Neurol Sci 347(1\u20132):251\u2013256. https:\/\/doi.org\/10.1016\/j.jns.2014.10.009","journal-title":"J Neurol Sci"},{"key":"2939_CR69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1080\/13813455.2019.1684954","volume":"128","author":"M Ergenc","year":"2019","unstructured":"Ergenc M, Ozacmak HS, Turan I, Ozacmak VH (2019) Melatonin reverses depressive and anxiety like-behaviours induced by diabetes: involvement of oxidative stress, age, rage and S100B levels in the hippocampus and prefrontal cortex of rats. Arch Physiol Biochem 128:402\u2013410. https:\/\/doi.org\/10.1080\/13813455.2019.1684954","journal-title":"Arch Physiol Biochem"},{"key":"2939_CR70","doi-asserted-by":"publisher","first-page":"103520","DOI":"10.1016\/j.msard.2022.103520","volume":"58","author":"BM Escribano","year":"2022","unstructured":"Escribano BM et al (2022) Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Multi Scler Relat Disord 58:103520. https:\/\/doi.org\/10.1016\/j.msard.2022.103520","journal-title":"Multi Scler Relat Disord"},{"issue":"18","key":"2939_CR71","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1093\/hmg\/dds227","volume":"21","author":"B Etain","year":"2012","unstructured":"Etain B, Dumaine A, Bellivier F, Pagan C, Francelle L, Goubran-Botros H, Moreno S, Deshommes J, Moustafa K, Le Dudal K, Mathieu F, Henry C, Kahn JP, Launay JM, M\u00fchleisen TW, Cichon S, Bourgeron T, Leboyer M, Jamain S (2012) Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Human Mol Genet 21(18):4030\u20134037. https:\/\/doi.org\/10.1093\/hmg\/dds227","journal-title":"Human Mol Genet"},{"issue":"6","key":"2939_CR72","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cell.2015.08.025","volume":"162","author":"MF Farez","year":"2015","unstructured":"Farez MF, Mascanfroni ID, M\u00e9ndez-Huergo SP, Yeste A, Murugaiyan G, Garo LP, Balbuena Aguirre ME, Patel B, Ysrraelit MC, Zhu C, Kuchroo VK, Rabinovich GA, Quintana FJ, Correale J (2015) Melatonin contributes to the seasonality of multiple sclerosis relapses. Cell 162(6):1338\u20131352. https:\/\/doi.org\/10.1016\/j.cell.2015.08.025","journal-title":"Cell"},{"key":"2939_CR73","doi-asserted-by":"publisher","first-page":"1835195","DOI":"10.1155\/2017\/1835195","volume":"2017","author":"G Favero","year":"2017","unstructured":"Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R (2017) Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J Endocrinol 2017:1835195. https:\/\/doi.org\/10.1155\/2017\/1835195","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2939_CR74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.freeradbiomed.2005.03.007","volume":"39","author":"Z Feng","year":"2005","unstructured":"Feng Z, Zhang JT (2005) Long-term melatonin or 17beta-estradiol supplementation alleviates oxidative stress in ovariectomized adult rats. Free Rad Biol Med 39(2):195\u2013204. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.03.007","journal-title":"Free Rad Biol Med"},{"key":"2939_CR75","doi-asserted-by":"publisher","first-page":"110626","DOI":"10.1016\/j.pnpbp.2022.110626","volume":"120","author":"Z Fi\u0161ar","year":"2023","unstructured":"Fi\u0161ar Z (2023) Biological hypotheses, risk factors, and biomarkers of schizophrenia. Progress Neuro-Psychopharmacol Biol Psychiatry 120:110626. https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110626","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"12","key":"2939_CR76","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s00213-016-4272-3","volume":"233","author":"W Fu","year":"2016","unstructured":"Fu W, Xie H, Laudon M, Zhou S, Tian S, You Y (2016) Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats. Psychopharmacol 233(12):2229\u20132239. https:\/\/doi.org\/10.1007\/s00213-016-4272-3","journal-title":"Psychopharmacol"},{"issue":"3","key":"2939_CR77","doi-asserted-by":"publisher","first-page":"e12421","DOI":"10.1111\/jpi.12421.10.1111\/jpi.12421","volume":"63","author":"T Galv\u00e1n-Arrieta","year":"2017","unstructured":"Galv\u00e1n-Arrieta T, Trueta C, Cerc\u00f3s MG, Vald\u00e9s-Tovar M, Alarc\u00f3n S, Oikawa J, Zamudio-Meza H, Ben\u00edtez-King G (2017) The role of melatonin in the neurodevelopmental etiology of schizophrenia: a study in human olfactory neuronal precursors. J Pineal Res 63(3):e12421. https:\/\/doi.org\/10.1111\/jpi.12421.10.1111\/jpi.12421","journal-title":"J Pineal Res"},{"issue":"1","key":"2939_CR78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/rej.2015.1704","volume":"19","author":"SA Ganie","year":"2016","unstructured":"Ganie SA, Dar TA, Bhat AH, Dar KB, Anees S, Zargar MA, Masood A (2016) Melatonin: a potential anti-oxidant therapeutic agent for mitochondrial dysfunctions and related disorders. Rejuv Res 19(1):21\u201340. https:\/\/doi.org\/10.1089\/rej.2015.1704","journal-title":"Rejuv Res"},{"key":"2939_CR79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neubiorev.2018.12.025","volume":"99","author":"R Genario","year":"2019","unstructured":"Genario R, Giacomini A, Demin KA, Dos Santos BE, Marchiori NI, Volgin AD, Bashirzade A, Amstislavskaya TG, de Abreu MS, Kalueff AV (2019) The evolutionarily conserved role of melatonin in CNS disorders and behavioral regulation: translational lessons from zebrafish. Neurosci Biobehav Rev 99:117\u2013127. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.12.025","journal-title":"Neurosci Biobehav Rev"},{"key":"2939_CR80","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s10571-018-0580-y","volume":"38","author":"M Ghareghani","year":"2018","unstructured":"Ghareghani M et al (2018) Spasticity treatment ameliorates the efficacy of melatonin therapy in experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis. Cell Mol Neurobiol 38:1145\u20131151. https:\/\/doi.org\/10.1007\/s10571-018-0580-y","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"2939_CR81","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.29399\/npa.27467","volume":"58","author":"\u015e Gica","year":"2021","unstructured":"Gica \u015e, Selv\u0131 Y (2021) Sleep interventions in the treatment of schizophrenia and bipolar disorder. Noro Psikiyatri arsivi 58(1):S53\u2013S60. https:\/\/doi.org\/10.29399\/npa.27467","journal-title":"Noro Psikiyatri arsivi"},{"key":"2939_CR82","doi-asserted-by":"publisher","first-page":"115831","DOI":"10.1016\/j.bcp.2023.115831","volume":"217","author":"A Giri","year":"2023","unstructured":"Giri A, Mehan S, Khan Z, Gupta GD, Narula AS (2023) Melatonin-mediated IGF-1\/GLP-1 activation in experimental OCD rats: evidence from CSF, blood plasma, brain and in-silico investigations. Biochem Pharmacol 217:115831. https:\/\/doi.org\/10.1016\/j.bcp.2023.115831","journal-title":"Biochem Pharmacol"},{"key":"2939_CR83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejphar.2015.05.032","volume":"762","author":"DA Golombek","year":"2015","unstructured":"Golombek DA, Pandi-Perumal SR, Brown GM, Cardinali DP (2015) Some implications of melatonin use in chronopharmacology of insomnia. Eur J Pharmacol 762:42\u201348. https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.032","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2939_CR84","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-079x.2012.01023.x","volume":"54","author":"M Gonciarz","year":"2012","unstructured":"Gonciarz M, Biela\u0144ski W, Partyka R, Brzozowski T, Konturek PC, Eszyk J, Konturek SJ (2012) Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin. J Pineal Res 54(2):154\u2013161. https:\/\/doi.org\/10.1111\/j.1600-079x.2012.01023.x","journal-title":"J Pineal Res"},{"issue":"1","key":"2939_CR85","first-page":"35","volume":"63","author":"M Gonciarz","year":"2012","unstructured":"Gonciarz M, Gonciarz Z, Bielanski W, Mularczyk A, Konturek PC, Brzozowski T, Konturek SJ (2012) The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study. J Physiol Pharmacol Off J Polish Physiol Soc 63(1):35\u201340","journal-title":"J Physiol Pharmacol Off J Polish Physiol Soc"},{"issue":"5","key":"2939_CR86","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC, Feldman EL (2022) Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol 21(5):465\u2013479. https:\/\/doi.org\/10.1016\/S1474-4422(21)00414-2","journal-title":"Lancet Neurol"},{"key":"2939_CR87","doi-asserted-by":"publisher","unstructured":"Govitrapong P, Ekthuwapranee K, Ruksee N, Boontem P (2016) Melatonin, a neuroprotective agent: relevance for stress-induced neuropsychiatric disorders. In: L\u00f3pez-Mu\u00f1oz, F., Srinivasan, V., de Berardis, D., \u00c1lamo, C., Kato, T. (eds) Melatonin, Neuroprotective Agents and Antidepressant Therapy. Springer, New Delhi. https:\/\/doi.org\/10.1007\/978-81-322-2803-5_8","DOI":"10.1007\/978-81-322-2803-5_8"},{"issue":"8","key":"2939_CR88","doi-asserted-by":"publisher","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"LI Grad","year":"2017","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harbor Perspect Med 7(8):a024117. https:\/\/doi.org\/10.1101\/cshperspect.a024117","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"11","key":"2939_CR89","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaac.2017.09.414","volume":"56","author":"P Gringras","year":"2017","unstructured":"Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL (2017) Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adol Psychiatry 56(11):948-957.e4. https:\/\/doi.org\/10.1016\/j.jaac.2017.09.414","journal-title":"J Am Acad Child Adol Psychiatry"},{"key":"2939_CR90","doi-asserted-by":"publisher","first-page":"1218506","DOI":"10.3389\/fphar.2023.1218506","volume":"14","author":"S Gumbar","year":"2023","unstructured":"Gumbar S, Bhardwaj S, Mehan S, Khan Z, Narula AS, Kalfin R, Tabrez S, Zughaibi TA, Wasi S (2023) Renal mitochondrial restoration by gymnemic acid in gentamicin-mediated experimental nephrotoxicity: evidence from serum, kidney and histopathological alterations. Front Pharmacol 14:1218506. https:\/\/doi.org\/10.3389\/fphar.2023.1218506","journal-title":"Front Pharmacol"},{"issue":"3","key":"2939_CR91","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neurol.2019.07.025","volume":"176","author":"M Gunata","year":"2020","unstructured":"Gunata M, Parlakpinar H, Acet HA (2020) Melatonin: a review of its potential functions and effects on neurological diseases. Rev Neurologique 176(3):148\u2013165. https:\/\/doi.org\/10.1016\/j.neurol.2019.07.025","journal-title":"Rev Neurologique"},{"issue":"3","key":"2939_CR92","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1567202612666150603130235","volume":"12","author":"S Gupta","year":"2015","unstructured":"Gupta S, Singh P, Sharma BM, Sharma B (2015) Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia. Curr Neurovasc Res 12(3):240\u2013252. https:\/\/doi.org\/10.2174\/1567202612666150603130235","journal-title":"Curr Neurovasc Res"},{"issue":"11","key":"2939_CR93","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.023","volume":"25","author":"S Gupta","year":"2016","unstructured":"Gupta S, Singh P, Sharma B (2016) neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia. J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc 25(11):2717\u20132728. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.07.023","journal-title":"J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc"},{"key":"2939_CR94","doi-asserted-by":"publisher","first-page":"640389","DOI":"10.1100\/2012\/640389","volume":"2012","author":"R Hardeland","year":"2012","unstructured":"Hardeland R (2012) Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. Sci World J 2012:640389. https:\/\/doi.org\/10.1100\/2012\/640389","journal-title":"Sci World J"},{"issue":"5","key":"2939_CR95","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/ijms20051223","volume":"20","author":"R Hardeland","year":"2019","unstructured":"Hardeland R (2019) Aging, melatonin, and the pro- and anti-inflammatory networks. Int J Mol Sci 20(5):1223. https:\/\/doi.org\/10.3390\/ijms20051223","journal-title":"Int J Mol Sci"},{"key":"2939_CR96","doi-asserted-by":"publisher","first-page":"102251","DOI":"10.1016\/j.redox.2022.102251","volume":"51","author":"P Heher","year":"2022","unstructured":"Heher P, Ganassi M, Weidinger A, Engquist EN, Pruller J, Nguyen TH, Tassin A, Decl\u00e8ves AE, Mamchaoui K, Banerji CRS, Grillari J, Kozlov AV, Zammit PS (2022) Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: metabolic stress as potential therapeutic target. Redox Biol 51:102251. https:\/\/doi.org\/10.1016\/j.redox.2022.102251","journal-title":"Redox Biol"},{"issue":"6","key":"2939_CR97","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in alzheimer disease. Nat Rev Neurosci 16(6):358\u2013372. https:\/\/doi.org\/10.1038\/nrn3880","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"2939_CR98","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jpi.12210","volume":"58","author":"D Hevia","year":"2015","unstructured":"Hevia D, Gonz\u00e1lez-Men\u00e9ndez P, Quiros-Gonz\u00e1lez I, Miar A, Rodr\u00edguez-Garc\u00eda A, Tan D-X, Sainz RM (2015) Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer. J Pineal Res 58(2):234\u2013250. https:\/\/doi.org\/10.1111\/jpi.12210","journal-title":"J Pineal Res"},{"issue":"2","key":"2939_CR99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1600-079x.2011.00871.x","volume":"51","author":"Y Hibaoui","year":"2011","unstructured":"Hibaoui Y, Reutenauer-Patte J, Patthey-Vuadens O, Ruegg UT, Dorchies OM (2011) Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for duchenne muscular dystrophy. J Pineal Res 51(2):163\u2013171. https:\/\/doi.org\/10.1111\/j.1600-079x.2011.00871.x","journal-title":"J Pineal Res"},{"issue":"12","key":"2939_CR100","doi-asserted-by":"publisher","first-page":"8255","DOI":"10.1007\/s12035-019-01660-3","volume":"56","author":"MF Hossain","year":"2019","unstructured":"Hossain MF, Uddin MS, Uddin G, Sumsuzzman DM, Islam MS, Barreto GE, Mathew B, Ashraf GM (2019) Melatonin in alzheimer\u2019s disease: a latent endogenous regulator of neurogenesis to mitigate alzheimer\u2019s neuropathology. Mol Neurobiol 56(12):8255\u20138276. https:\/\/doi.org\/10.1007\/s12035-019-01660-3","journal-title":"Mol Neurobiol"},{"key":"2939_CR101","doi-asserted-by":"publisher","first-page":"1265789","DOI":"10.3389\/fneur.2023.1265789","volume":"14","author":"S Iftikhar","year":"2023","unstructured":"Iftikhar S et al (2023) Significant potential of melatonin therapy in parkinson\u2019s disease\u2014a meta-analysis of randomized controlled trials. Front Neurol 14:1265789. https:\/\/doi.org\/10.3389\/fneur.2023.1265789","journal-title":"Front Neurol"},{"issue":"3","key":"2939_CR102","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/1574884716666210726110021","volume":"17","author":"KS Jadaun","year":"2022","unstructured":"Jadaun KS, Sharma A, Siddiqui EM, Mehan S (2022) Targeting abnormal PI3K\/AKT\/mTOR signaling in intracerebral hemorrhage: a systematic review on potential drug targets and influences of signaling modulators on other neurological disorders. Curr Rev Clin Exp Pharmacol 17(3):174\u2013191. https:\/\/doi.org\/10.2174\/1574884716666210726110021","journal-title":"Curr Rev Clin Exp Pharmacol"},{"issue":"9","key":"2939_CR103","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.amjmed.2018.04.009","volume":"131","author":"SJ Jaiswal","year":"2018","unstructured":"Jaiswal SJ, McCarthy TJ, Wineinger NE, Kang DY, Song J, Garcia S, van Niekerk CJ, Lu CY, Loeks M, Owens RL (2018) Melatonin and sleep in preventing hospitalized delirium: a randomized clinical trial. Am J Med 131(9):1110-1117.e4. https:\/\/doi.org\/10.1016\/j.amjmed.2018.04.009","journal-title":"Am J Med"},{"key":"2939_CR104","doi-asserted-by":"publisher","first-page":"5577541","DOI":"10.1155\/2021\/5577541","volume":"2021","author":"A Jim\u00e9nez-Delgado","year":"2021","unstructured":"Jim\u00e9nez-Delgado A, Ortiz GG, Delgado-Lara DL, Gonz\u00e1lez-Usigli HA, Gonz\u00e1lez-Ortiz LJ, Cid-Hern\u00e1ndez M, Cruz-Serrano JA, Pacheco-Mois\u00e9s FP (2021) Effect of melatonin administration on mitochondrial activity and oxidative stress markers in patients with parkinson\u2019s disease. Oxid Med Cell Long 2021:5577541. https:\/\/doi.org\/10.1155\/2021\/5577541","journal-title":"Oxid Med Cell Long"},{"key":"2939_CR105","doi-asserted-by":"crossref","unstructured":"Joshua AM, Misri Z (2022) Motor neuron disease. In:\u00a0Physiotherapy for Adult Neurological Conditions\u00a0(pp. 539-562). Singapore: Springer Nature Singapore","DOI":"10.1007\/978-981-19-0209-3_8"},{"issue":"21","key":"2939_CR106","doi-asserted-by":"publisher","first-page":"11847","DOI":"10.3390\/ijms222111847","volume":"22","author":"A Jurcau","year":"2021","unstructured":"Jurcau A (2021) Insights into the pathogenesis of neurodegenerative diseases: focus on mitochondrial dysfunction and oxidative stress. Int J Mol Sci 22(21):11847. https:\/\/doi.org\/10.3390\/ijms222111847","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2939_CR107","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/mds.26003","volume":"29","author":"E Kalliolia","year":"2014","unstructured":"Kalliolia E, Silajd\u017ei\u0107 E, Nambron R, Hill NR, Doshi A, Frost C, Warner TT (2014) Plasma melatonin is reduced in Huntington\u2019s disease. Move Disord 29(12):1511\u20131515. https:\/\/doi.org\/10.1002\/mds.26003","journal-title":"Move Disord"},{"issue":"5","key":"2939_CR108","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/2167702614521188","volume":"2","author":"A Karmiloff-Smith","year":"2014","unstructured":"Karmiloff-Smith A, Casey BJ, Massand E, Tomalski P, Thomas MS (2014) Environmental and genetic influences on neurocognitive development: the importance of multiple methodologies and time-dependent intervention. Clin Psychologic Sci J Assoc Psychologic Sci 2(5):628\u2013637. https:\/\/doi.org\/10.1177\/2167702614521188","journal-title":"Clin Psychologic Sci J Assoc Psychologic Sci"},{"issue":"1","key":"2939_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10072-018-3585-x","volume":"40","author":"R Kaur","year":"2019","unstructured":"Kaur R, Mehan S, Singh S (2019) Understanding multifactorial architecture of parkinson\u2019s disease: pathophysiology to management. Neurol Sci off J Italian Neurol Soc Italian Soc Clin Neurophysiol 40(1):13\u201323. https:\/\/doi.org\/10.1007\/s10072-018-3585-x","journal-title":"Neurol Sci off J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"issue":"3","key":"2939_CR110","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1590\/s1516-31802012000300006","volume":"130","author":"S Khaleghipour","year":"2012","unstructured":"Khaleghipour S, Masjedi M, Ahade H, Enayate M, Pasha G, Nadery F, Ahmadzade G (2012) Morning and nocturnal serum melatonin rhythm levels in patients with major depressive disorder: an analytical cross-sectional study. Sao Paulo Med J Rev Paulista de Med 130(3):167\u2013172. https:\/\/doi.org\/10.1590\/s1516-31802012000300006","journal-title":"Sao Paulo Med J Rev Paulista de Med"},{"issue":"8","key":"2939_CR111","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/biomedicines8080284","volume":"8","author":"A Khan","year":"2020","unstructured":"Khan A, Jahan S, Imtiyaz Z, Alshahrani S, Antar Makeen H, Mohammed Alshehri B, Kumar A, Arafah A, Rehman MU (2020) Neuroprotection: targeting multiple pathways by naturally occurring phytochemicals. Biomedicines 8(8):284. https:\/\/doi.org\/10.3390\/biomedicines8080284","journal-title":"Biomedicines"},{"issue":"13","key":"2939_CR112","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.3390\/jcm12134274","volume":"12","author":"Z Khan","year":"2023","unstructured":"Khan Z, Gupta GD, Mehan S (2023) Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges. J Clin Med 12(13):4274. https:\/\/doi.org\/10.3390\/jcm12134274","journal-title":"J Clin Med"},{"issue":"6","key":"2939_CR113","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1007\/s12035-022-02819-1","volume":"59","author":"R Khera","year":"2022","unstructured":"Khera R, Mehan S, Kumar S, Sethi P, Bhalla S, Prajapati A (2022) Role of JAK-STAT and PPAR-gamma signalling modulators in the prevention of autism and neurological dysfunctions. Mol Neurobiol 59(6):3888\u20133912. https:\/\/doi.org\/10.1007\/s12035-022-02819-1","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2939_CR114","doi-asserted-by":"publisher","first-page":"163","DOI":"10.12793\/tcp.2022.30.e21","volume":"30","author":"HK Kim","year":"2022","unstructured":"Kim HK, Yang KI (2022) Melatonin and melatonergic drugs in sleep disorders. Transl Clin Pharmacol 30(4):163\u2013171","journal-title":"Transl Clin Pharmacol"},{"key":"2939_CR115","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12974-014-0218-z","volume":"11","author":"PF Kinoshita","year":"2014","unstructured":"Kinoshita PF, Yshii LM, Vasconcelos AR, Orellana AM, Lima LD, Davel AP, Rossoni LV, Kawamoto EM, Scavone C (2014) Signaling function of na, K-ATPase induced by ouabain against LPS as an inflammation model in hippocampus. J Neuroinflamm 11:218. https:\/\/doi.org\/10.1186\/s12974-014-0218-z","journal-title":"J Neuroinflamm"},{"key":"2939_CR116","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuroscience.2013","volume":"260","author":"GS Kirshenbaum","year":"2014","unstructured":"Kirshenbaum GS, Burgess CR, D\u00e9ry N, Fahnestock M, Peever JH, Roder JC (2014) Attenuation of mania-like behavior in Na+, K+-ATPase \u03b13 mutant mice by prospective therapies for bipolar disorder: melatonin and exercise. Neuroscience 260:195\u2013204. https:\/\/doi.org\/10.1016\/j.neuroscience.2013","journal-title":"Neuroscience"},{"issue":"1","key":"2939_CR117","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/apa.15485","volume":"110","author":"MS Knoop","year":"2021","unstructured":"Knoop MS, de Groot ER, Dudink J (2021) Current ideas about the roles of rapid eye movement and non-rapid eye movement sleep in brain development. Acta Paediatrica (Oslo, Norway: 1992) 110(1):36\u201344. https:\/\/doi.org\/10.1111\/apa.15485","journal-title":"Acta Paediatrica (Oslo, Norway: 1992)"},{"issue":"1","key":"2939_CR118","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.0","volume":"228","author":"T Kudo","year":"2011","unstructured":"Kudo T, Schroeder A, Loh DH, Kuljis D, Jordan MC, Roos KP, Colwell CS (2011) Dysfunctions in circadian behavior and physiology in mouse models of Huntington\u2019s disease. Exp Neurol 228(1):80\u201390. https:\/\/doi.org\/10.1016\/j.expneurol.2010.12.0","journal-title":"Exp Neurol"},{"issue":"10","key":"2939_CR119","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/07420528.2021.1930028","volume":"38","author":"N Kudo","year":"2021","unstructured":"Kudo N, Shinohara H, Kagabu S, Kodama H (2021) Evaluation of salivary melatonin concentrations as a circadian phase maker of morning awakening and their association with depressive mood in postpartum mothers. Chronobiol Int 38(10):1409\u20131420. https:\/\/doi.org\/10.1080\/07420528.2021.1930028","journal-title":"Chronobiol Int"},{"issue":"5","key":"2939_CR120","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11011-021-00691-x","volume":"36","author":"N Kumar","year":"2021","unstructured":"Kumar N, Sharma N, Khera R, Gupta R, Mehan S (2021) Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain. Metab Brain Dis 36(5):911\u2013925. https:\/\/doi.org\/10.1007\/s11011-021-00691-x","journal-title":"Metab Brain Dis"},{"issue":"8","key":"2939_CR121","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines9080918","volume":"9","author":"HC Kung","year":"2021","unstructured":"Kung HC, Lin KJ, Kung CT, Lin TK (2021) Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in parkinson\u2019s disease. Biomedicines 9(8):918. https:\/\/doi.org\/10.3390\/biomedicines9080918","journal-title":"Biomedicines"},{"issue":"12","key":"2939_CR122","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.4088\/JCP.10m06347yel","volume":"71","author":"M Leboyer","year":"2010","unstructured":"Leboyer M, Kupfer DJ (2010) Bipolar disorder: new perspectives in health care and prevention. J Clinic Psychiatry 71(12):1689\u20131695. https:\/\/doi.org\/10.4088\/JCP.10m06347yel","journal-title":"J Clinic Psychiatry"},{"issue":"1","key":"2939_CR123","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12868-018-0439-7","volume":"19","author":"B Lee","year":"2018","unstructured":"Lee B, Shim I, Lee H, Hahm DH (2018) Melatonin ameliorates cognitive memory by regulation of cAMP-response element-binding protein expression and the anti-inflammatory response in a rat model of post-traumatic stress disorder. BMC Neurosci 19(1):38. https:\/\/doi.org\/10.1186\/s12868-018-0439-7","journal-title":"BMC Neurosci"},{"issue":"10","key":"2939_CR124","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/brainsci9100285","volume":"9","author":"JG Lee","year":"2019","unstructured":"Lee JG, Woo YS, Park SW, Seog DH, Seo MK, Bahk WM (2019) The neuroprotective effects of melatonin: possible role in the pathophysiology of neuropsychiatric disease. Brain Sci 9(10):285. https:\/\/doi.org\/10.3390\/brainsci9100285","journal-title":"Brain Sci"},{"issue":"7","key":"2939_CR125","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1139\/apnm-2016-0677","volume":"42","author":"RC Leonardo-Mendon\u00e7a","year":"2017","unstructured":"Leonardo-Mendon\u00e7a RC, Oca\u00f1a-Wilhelmi J, de Haro T, de Teresa-Galv\u00e1n C, Guerra-Hern\u00e1ndez E, Rusanova I, Acu\u00f1a-Castroviejo D (2017) The benefit of a supplement with the antioxidant melatonin on redox status and muscle damage in resistance-trained athletes. Appl Physiol Nutr Metab 42(7):700\u2013707. https:\/\/doi.org\/10.1139\/apnm-2016-0677","journal-title":"Appl Physiol Nutr Metab"},{"issue":"2","key":"2939_CR126","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","volume":"44","author":"CH Lin","year":"2008","unstructured":"Lin CH, Huang JY, Ching CH, Chuang JI (2008) Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats. J Pineal Res 44(2):205\u2013213. https:\/\/doi.org\/10.1111\/j.1600-079X.2007.00510.x","journal-title":"J Pineal Res"},{"issue":"2","key":"2939_CR127","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JAD-2009-0949","volume":"16","author":"ZQ Ling","year":"2009","unstructured":"Ling ZQ, Tian Q, Wang L, Fu ZQ, Wang XC, Wang Q, Wang JZ (2009) Constant illumination induces alzheimer-like damages with endoplasmic reticulum involvement and the protection of melatonin. Journal of Alzheimer\u2019s disease\u202f: JAD 16(2):287\u2013300. https:\/\/doi.org\/10.3233\/JAD-2009-0949","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"key":"2939_CR128","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","volume":"56","author":"J Liu","year":"2016","unstructured":"Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML (2016) MT1 and MT2 melatonin receptors: a therapeutic perspective. Annual Rev Pharmacol Toxicol 56:361\u2013383. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010814-124742","journal-title":"Annual Rev Pharmacol Toxicol"},{"issue":"1","key":"2939_CR129","doi-asserted-by":"publisher","first-page":"15627","DOI":"10.1038\/s41598-019-52058-z","volume":"9","author":"A Lopachev","year":"2019","unstructured":"Lopachev A, Volnova A, Evdokimenko A, Abaimov D, Timoshina Y, Kazanskaya R, Lopacheva O, Deal A, Budygin E, Fedorova T, Gainetdinov R (2019) Intracerebroventricular injection of ouabain causes mania-like behavior in mice through D2 receptor activation. Sci Rep 9(1):15627. https:\/\/doi.org\/10.1038\/s41598-019-52058-z","journal-title":"Sci Rep"},{"key":"2939_CR130","doi-asserted-by":"publisher","first-page":"504678","DOI":"10.1155\/2015\/504678","volume":"2015","author":"M Luca","year":"2015","unstructured":"Luca M, Luca A, Calandra C (2015) The role of oxidative damage in the pathogenesis and progression of alzheimer\u2019s disease and vascular dementia. Oxid Med and Cell Long 2015:504678. https:\/\/doi.org\/10.1155\/2015\/504678","journal-title":"Oxid Med and Cell Long"},{"issue":"19","key":"2939_CR131","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.3390\/ijms21197174","volume":"21","author":"F Luo","year":"2020","unstructured":"Luo F, Sandhu AF, Rungratanawanich W, Williams GE, Akbar M, Zhou S, Wang X (2020) Melatonin and autophagy in aging-related neurodegenerative diseases. Int J Mol Sci 21(19):7174. https:\/\/doi.org\/10.3390\/ijms21197174","journal-title":"Int J Mol Sci"},{"key":"2939_CR132","doi-asserted-by":"publisher","first-page":"110109","DOI":"10.1016\/j.pnpbp.2020.110109","volume":"111","author":"T Lwin","year":"2021","unstructured":"Lwin T, Yang JL, Ngampramuan S, Viwatpinyo K, Chancharoen P, Veschsanit N, Pinyomahakul J, Govitrapong P, Mukda S (2021) Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4\/MyD88\/NF\u03baB signaling pathway in the mouse hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 111:110109. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110109","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2939_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9286458","volume":"2018","author":"S Ma","year":"2018","unstructured":"Ma S, Chen J, Feng J, Zhang R, Fan M, Han D, Cao F (2018) Melatonin ameliorates the progression of atherosclerosis via mitophagy activation and NLRP3 inflammasome inhibition. Oxid Med Cell Long 2018:1\u201312. https:\/\/doi.org\/10.1155\/2018\/9286458","journal-title":"Oxid Med Cell Long"},{"key":"2939_CR134","doi-asserted-by":"publisher","first-page":"784314","DOI":"10.3389\/fnagi.2022.784314","volume":"14","author":"H Ma","year":"2022","unstructured":"Ma H, Yan J, Sun W, Jiang M, Zhang Y (2022) Melatonin treatment for sleep disorders in parkinson\u2019s disease: a meta-analysis and systematic review. Front Aging Neurosci 14:784314. https:\/\/doi.org\/10.3389\/fnagi.2022.784314","journal-title":"Front Aging Neurosci"},{"key":"2939_CR135","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/7854_2010_51","volume":"5","author":"R Machado-Vieira","year":"2011","unstructured":"Machado-Vieira R, Manji HK, Zarate CA Jr (2011) Potential novel therapeutics for bipolar disorders. Curr Top Behav Neurosci 5:303\u2013329. https:\/\/doi.org\/10.1007\/7854_2010_51","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"2939_CR136","first-page":"7","volume":"32","author":"M Maes","year":"2011","unstructured":"Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J (2011) Depression\u2019s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 32(1):7\u201324","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"2939_CR137","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/a-0656-6643","volume":"69","author":"D Mahmood","year":"2019","unstructured":"Mahmood D (2019) Pleiotropic effects of melatonin. Drug Res 69(2):65\u201374. https:\/\/doi.org\/10.1055\/a-0656-6643","journal-title":"Drug Res"},{"issue":"3","key":"2939_CR138","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejbas.2016.07.001","volume":"3","author":"D Mahmood","year":"2016","unstructured":"Mahmood D, Muhammad BY, Alghani M, Anwar J, el-Lebban N, Haider M (2016) Advancing role of melatonin in the treatment of neuropsychiatric disorders. Egyp J Basic Appl Sci 3(3):203\u2013218. https:\/\/doi.org\/10.1016\/j.ejbas.2016.07.001","journal-title":"Egyp J Basic Appl Sci"},{"issue":"3","key":"2939_CR139","first-page":"64","volume":"11","author":"GS Mahmoud","year":"2019","unstructured":"Mahmoud GS, El-Deek HE (2019) Melatonin modulates inflammatory mediators and improves olanzapine-induced hepatic steatosis in rat model of schizophrenia. Int J Physiol Pathophysiol Pharmacol 11(3):64\u201375","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"10","key":"2939_CR140","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00228-022-03363-6","volume":"78","author":"R Majidazar","year":"2022","unstructured":"Majidazar R, Rezazadeh-Gavgani E, Sadigh-Eteghad S, Naseri A (2022) Pharmacotherapy of alzheimer\u2019s disease: an overview of systematic reviews. Eur J Clin Pharmacol. 78(10):1567\u20131587. https:\/\/doi.org\/10.1007\/s00228-022-03363-6","journal-title":"Eur J Clin Pharmacol."},{"issue":"8","key":"2939_CR141","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10803-011-1418-3","volume":"42","author":"B Malow","year":"2011","unstructured":"Malow B, Adkins KW, McGrew SG, Wang L, Goldman SE, Fawkes D, Burnette C (2011) Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Devel Disord 42(8):1729\u20131737. https:\/\/doi.org\/10.1007\/s10803-011-1418-3","journal-title":"J Autism Devel Disord"},{"issue":"3","key":"2939_CR142","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3171\/2018.3.JNS172274","volume":"131","author":"A Mansour","year":"2018","unstructured":"Mansour A, Niizuma K, Rashad S, Sumiyoshi A, Ryoke R, Endo H, Endo T, Sato K, Kawashima R, Tominaga T (2018) A refined model of chronic cerebral hypoperfusion resulting in cognitive impairment and a low mortality rate in rats. J Neurosurge 131(3):892\u2013902. https:\/\/doi.org\/10.3171\/2018.3.JNS172274","journal-title":"J Neurosurge"},{"issue":"8","key":"2939_CR143","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1111\/febs.15716","volume":"289","author":"K Mao","year":"2022","unstructured":"Mao K, Zhang G (2022) The role of PARP1 in neurodegenerative diseases and aging. Federat Eur Biochem Soc FEBS J 289(8):2013\u20132024. https:\/\/doi.org\/10.1111\/febs.15716","journal-title":"Federat Eur Biochem Soc FEBS J"},{"issue":"10","key":"2939_CR144","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ni.2695","volume":"14","author":"ID Mascanfroni","year":"2013","unstructured":"Mascanfroni ID, Yeste A, Vieira SM, Burns EJ, Patel B, Sloma I, Wu Y, Mayo L, Ben-Hamo R, Efroni S, Kuchroo VK, Robson SC, Quintana FJ (2013) IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 14(10):1054\u20131063. https:\/\/doi.org\/10.1038\/ni.2695","journal-title":"Nat Immunol"},{"key":"2939_CR145","doi-asserted-by":"publisher","unstructured":"Matilla-Due\u00f1as A\u00a0(2017) Rare neurodegenerative diseases: clinical and genetic update. In: Posada de la Paz, M., Taruscio, D., Groft, S. (eds) Rare Diseases Epidemiology: Update and Overview. Advances in Experimental Medicine and Biology, vol 1031. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-67144-4_25","DOI":"10.1007\/978-3-319-67144-4_25"},{"issue":"1","key":"2939_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-079X.2012.01014.x","volume":"54","author":"JL Mauriz","year":"2013","unstructured":"Mauriz JL, Collado PS, Veneroso C, Reiter RJ, Gonz\u00e1lez-Gallego J (2013) A review of the molecular aspects of melatonin\u2019s anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 54(1):1\u201314. https:\/\/doi.org\/10.1111\/j.1600-079X.2012.01014.x","journal-title":"J Pineal Res"},{"issue":"2","key":"2939_CR147","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Reis Marques T, Howes OD (2020) Schizophrenia\u2014an overview. JAMA Psychiatry 77(2):201\u2013210. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.3360","journal-title":"JAMA Psychiatry"},{"key":"2939_CR148","doi-asserted-by":"publisher","first-page":"134539","DOI":"10.1016\/j.neulet.2019.134539","volume":"714","author":"NB McNamara","year":"2020","unstructured":"McNamara NB, Miron VE (2020) Microglia in developing white matter and perinatal brain injury. Neurosci Lett 714:134539. https:\/\/doi.org\/10.1016\/j.neulet.2019.134539","journal-title":"Neurosci Lett"},{"issue":"5","key":"2939_CR149","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1586\/ern.13.39","volume":"13","author":"M Medina","year":"2013","unstructured":"Medina M, Avila J (2013) Understanding the relationship between GSK-3 and alzheimer\u2019s disease: a focus on how GSK-3 can modulate synaptic plasticity processes. Expert Rev Neurother 13(5):495\u2013503. https:\/\/doi.org\/10.1586\/ern.13.39","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"2939_CR150","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12031-010-9454-6","volume":"43","author":"S Mehan","year":"2010","unstructured":"Mehan S, Meena H, Sharma D, Sankhla R (2010) JNK: a stress-activated protein kinase therapeutic strategies and involvement in alzheimer\u2019s and various neurodegenerative abnormalities. J Mol Neurosci 43(3):376\u2013390. https:\/\/doi.org\/10.1007\/s12031-010-9454-6","journal-title":"J Mol Neurosci"},{"issue":"2","key":"2939_CR151","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4103\/1673-5374.200812","volume":"12","author":"S Mehan","year":"2017","unstructured":"Mehan S, Parveen S, Kalra S (2017) Adenyl cyclase activator forskolin protects against Huntington\u2019s disease-like neurodegenerative disorders. Neural Regen Res 12(2):290\u2013300. https:\/\/doi.org\/10.4103\/1673-5374.200812","journal-title":"Neural Regen Res"},{"issue":"6","key":"2939_CR152","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/ijp.IJP_11_18","volume":"50","author":"S Mehan","year":"2018","unstructured":"Mehan S, Monga V, Rani M, Dudi R, Ghimire K (2018) Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington\u2019s disease-like behavioral, biochemical, and cellular alterations: restoration of coenzyme-Q10-mediated mitochondrial dysfunction. Indian J Pharmacol Ind J Pharmacol 50(6):309\u2013319. https:\/\/doi.org\/10.4103\/ijp.IJP_11_18","journal-title":"Indian J Pharmacol Ind J Pharmacol"},{"issue":"6","key":"2939_CR153","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.4103\/1673-5374.270316","volume":"15","author":"S Mehan","year":"2020","unstructured":"Mehan S, Rahi S, Tiwari A, Kapoor T, Rajdev K, Sharma R, Khera H, Kosey S, Kukkar U, Dudi R (2020) Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats. Neur Regen Res 15(6):1140\u20131149. https:\/\/doi.org\/10.4103\/1673-5374.270316","journal-title":"Neur Regen Res"},{"key":"2939_CR154","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/DNND.S247153","volume":"12","author":"S Mehan","year":"2022","unstructured":"Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A (2022) Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration. Degen Neurol Neuromusc Dis 12:31\u201359. https:\/\/doi.org\/10.2147\/DNND.S247153","journal-title":"Degen Neurol Neuromusc Dis"},{"issue":"1","key":"2939_CR155","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41398-021-01464-x","volume":"11","author":"LM Melhuish Beaupre","year":"2021","unstructured":"Melhuish Beaupre LM, Brown GM, Gon\u00e7alves VF, Kennedy JL (2021) Melatonin\u2019s neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders. Trans Psychiatry 11(1):339. https:\/\/doi.org\/10.1038\/s41398-021-01464-x","journal-title":"Trans Psychiatry"},{"issue":"5","key":"2939_CR156","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/bcp.12092","volume":"76","author":"NM Merchant","year":"2013","unstructured":"Merchant NM, Azzopardi DV, Hawwa AF, McElnay JC, Middleton B, Arendt J, Arichi T, Gressens P, Edwards AD (2013) Pharmacokinetics of melatonin in preterm infants. Bri J Clin Pharmacol 76(5):725\u2013733. https:\/\/doi.org\/10.1111\/bcp.12092","journal-title":"Bri J Clin Pharmacol"},{"key":"2939_CR157","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","volume":"42","author":"U Meyer","year":"2013","unstructured":"Meyer U (2013) Developmental neuroinflammation and schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 42:20\u201334. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.11.003","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"2939_CR158","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/cells12010131","volume":"12","author":"DC Miculas","year":"2022","unstructured":"Miculas DC, Negru PA, Bungau SG, Behl T, Hassan SSU, Tit DM (2022) Pharmacotherapy evolution in alzheimer\u2019s disease: current framework and relevant directions. Cells. 12(1):131. https:\/\/doi.org\/10.3390\/cells12010131","journal-title":"Cells."},{"issue":"1","key":"2939_CR159","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nyas.14436","volume":"1478","author":"M Mihardja","year":"2020","unstructured":"Mihardja M, Roy J, Wong KY, Aquili L, Heng BC, Chan YS, Fung ML, Lim LW (2020) Therapeutic potential of neurogenesis and melatonin regulation in alzheimer\u2019s disease. Annals New York Acad Sci 1478(1):43\u201362. https:\/\/doi.org\/10.1111\/nyas.14436","journal-title":"Annals New York Acad Sci"},{"key":"2939_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.11.0","author":"A Mishra","year":"2019","unstructured":"Mishra A, Maiti R, Mishra BR, Jena M, Nath S, Sahu P (2019) Effect of add-on ramelteon therapy on sleep and circadian rhythm disruption in patients with schizophrenia: a randomized controlled trial. Eur Neuropsychopharmacol. https:\/\/doi.org\/10.1016\/j.euroneuro.2019.11.0","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"2939_CR161","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clinic Invest 121(2):493\u2013499. https:\/\/doi.org\/10.1172\/JCI45691","journal-title":"J Clinic Invest"},{"issue":"2","key":"2939_CR162","first-page":"87","volume":"7","author":"MR Mohammadi","year":"2012","unstructured":"Mohammadi MR, Mostafavi SA, Keshavarz SA, Eshraghian MR, Hosseinzadeh P, Hosseinzadeh-Attar MJ, Kooshesh SM, Chamari M, Akhondzadeh S (2012) Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iran J Psychiatry 7(2):87\u201392","journal-title":"Iran J Psychiatry"},{"key":"2939_CR163","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mrfmmm.2012.08.006","volume":"738-739","author":"M Mohseni","year":"2012","unstructured":"Mohseni M, Mihandoost E, Shirazi A, Sepehrizadeh Z, Bazzaz JT, Ghazikhansari M (2012) Melatonin may play a role in modulation of bax and bcl-2 expression levels to protect rat peripheral blood lymphocytes from gamma irradiation-induced apoptosis. Mutation research 738\u2013739:19\u201327. https:\/\/doi.org\/10.1016\/j.mrfmmm.2012.08.006","journal-title":"Mutation research"},{"key":"2939_CR164","doi-asserted-by":"publisher","first-page":"110162","DOI":"10.1016\/j.pnpbp.2020.110162","volume":"108","author":"E Moon","year":"2020","unstructured":"Moon E, Lavin P, Storch K-F, Linnaranta O (2020) Effects of antipsychotics on circadian rhythms in humans: a systematic review and meta-analysis. Progress in Neuro-Psychopharmacol Biol Psychiatry 108:110162. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110162","journal-title":"Progress in Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"5","key":"2939_CR165","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.3390\/ijms14059037","volume":"14","author":"AL Morera-Fumero","year":"2013","unstructured":"Morera-Fumero AL, Abreu-Gonzalez P (2013) Role of melatonin in schizophrenia. Int J Mol Sci 14(5):9037\u20139050. https:\/\/doi.org\/10.3390\/ijms14059037","journal-title":"Int J Mol Sci"},{"key":"2939_CR166","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.smrv.2018.03.007","volume":"41","author":"G Morris","year":"2018","unstructured":"Morris G, Stubbs B, K\u00f6hler CA, Walder K, Slyepchenko A, Berk M, Carvalho AF (2018) The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med Rev 41:255\u2013265","journal-title":"Sleep Med Rev"},{"issue":"5","key":"2939_CR167","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s10787-023-01271-4","volume":"31","author":"S Morsali","year":"2023","unstructured":"Morsali S, Sabahi Z, Kakaei J, Hakimzadeh Z, Hamidi S, Gholipour-Khalili E, Sanaie S, Talebi M, Naseri A (2023) Clinical efficacy and safety of melatonin supplementation in multiple sclerosis: a systematic review. Inflammopharmacology 31(5):2213\u20132220. https:\/\/doi.org\/10.1007\/s10787-023-01271-4","journal-title":"Inflammopharmacology"},{"key":"2939_CR168","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12624","author":"AJ Morton","year":"2019","unstructured":"Morton AJ, Middleton B, Rudiger S, Bawden CS, Kuchel TR, Skene DJ (2019) Increased plasma melatonin in presymptomatic Huntington disease sheep (Ovis aries): compensatory neuroprotection in a neurodegenerative disease? J Pineal Res. https:\/\/doi.org\/10.1111\/jpi.12624","journal-title":"J Pineal Res"},{"issue":"2","key":"2939_CR169","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11481-018-9824-3","volume":"14","author":"T Muhammad","year":"2019","unstructured":"Muhammad T, Ali T, Ikram M, Khan A, Alam SI, Kim MO (2019) Melatonin rescue oxidative stress-mediated neuroinflammation\/ neurodegeneration and memory impairment in scopolamine-induced amnesia mice model. J Neuroim Pharmacol Off J Soc NeuroI Pharmacol 14(2):278\u2013294. https:\/\/doi.org\/10.1007\/s11481-018-9824-3","journal-title":"J Neuroim Pharmacol Off J Soc NeuroI Pharmacol"},{"key":"2939_CR170","doi-asserted-by":"publisher","first-page":"4759963","DOI":"10.1155\/2022\/4759963","volume":"2022","author":"SU Nabi","year":"2022","unstructured":"Nabi SU, Khan A, Siddiqui EM, Rehman MU, Alshahrani S, Arafah A, Mehan S, Alsaffar RM, Alexiou A, Shen B (2022) Mechanisms of mitochondrial malfunction in alzheimer\u2019s disease: new therapeutic hope. Oxid Med Cell Longev 2022:4759963. https:\/\/doi.org\/10.1155\/2022\/4759963","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2939_CR171","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/ijms23010471","volume":"23","author":"G Nikolaev","year":"2021","unstructured":"Nikolaev G, Robeva R, Konakchieva R (2021) Membrane melatonin receptors activated cell signaling in physiology and disease. Int J Mol Sci 23(1):471. https:\/\/doi.org\/10.3390\/ijms23010471","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2939_CR172","doi-asserted-by":"publisher","first-page":"e12627","DOI":"10.1111\/jpi.12627","volume":"68","author":"YJ Niu","year":"2020","unstructured":"Niu YJ, Zhou W, Nie ZW, Shin KT, Cui XS (2020) Melatonin enhances mitochondrial biogenesis and protects against rotenone-induced mitochondrial deficiency in early porcine embryos. J Pineal Res 68(2):e12627. https:\/\/doi.org\/10.1111\/jpi.12627","journal-title":"J Pineal Res"},{"issue":"3","key":"2939_CR173","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12640-012-9331-x","volume":"22","author":"A Nunomura","year":"2012","unstructured":"Nunomura A, Moreira PI, Castellani RJ, Lee HG, Zhu X, Smith MA, Perry G (2012) Oxidative damage to RNA in aging and neurodegenerative disorders. Neurotoxic Res 22(3):231\u2013248. https:\/\/doi.org\/10.1007\/s12640-012-9331-x","journal-title":"Neurotoxic Res"},{"issue":"5","key":"2939_CR174","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.pharep.2016.04.003","volume":"68","author":"EA Og\u0142odek","year":"2016","unstructured":"Og\u0142odek EA, Just MJ, Szromek AR, Araszkiewicz A (2016) Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity. Pharmacologic Rep PR 68(5):945\u2013951. https:\/\/doi.org\/10.1016\/j.pharep.2016.04.003","journal-title":"Pharmacologic Rep PR"},{"issue":"8","key":"2939_CR175","doi-asserted-by":"publisher","first-page":"e2227","DOI":"10.1002\/brb3.2227","volume":"11","author":"NA Omeiza","year":"2021","unstructured":"Omeiza NA, Abdulrahim HA, Alagbonsi AI, Ezurike PU, Soluoku TK, Isiabor H, Alli-Oluwafuyi AA (2021) Melatonin salvages lead-induced neuro-cognitive shutdown, anxiety, and depressive-like symptoms via oxido-inflammatory and cholinergic mechanisms. Brain Behav 11(8):e2227. https:\/\/doi.org\/10.1002\/brb3.2227","journal-title":"Brain Behav"},{"key":"2939_CR176","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.biopha.2017.05.094","volume":"92","author":"AY Onaolapo","year":"2017","unstructured":"Onaolapo AY, Aina OA, Onaolapo OJ (2017) Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia. Biomed Pharmacother 92:373\u2013383. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.094","journal-title":"Biomed Pharmacother"},{"key":"2939_CR177","doi-asserted-by":"publisher","first-page":"688890","DOI":"10.3389\/fpsyt.2021.688890","volume":"12","author":"L Palagini","year":"2021","unstructured":"Palagini L, Manni R, Aguglia E, Amore M, Brugnoli R, Bioulac S, Bourgin P, Micoulaud Franchi JA, Girardi P, Grassi L, Lopez R, Mencacci C, Plazzi G, Maruani J, Minervino A, Philip P, Royant Parola S, Poirot I, Nobili L, Biggio G, Geoffroy PA (2021) International expert opinions and recommendations on the use of melatonin in the treatment of insomnia and circadian sleep disturbances in adult neuropsychiatric disorders. Front Psychiatry 12:688890. https:\/\/doi.org\/10.3389\/fpsyt.2021.688890","journal-title":"Front Psychiatry"},{"issue":"3","key":"2939_CR178","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","volume":"23","author":"SR Pandi-Perumal","year":"2013","unstructured":"Pandi-Perumal SR, BaHammam AS, Brown GM, Spence DW, Bharti VK, Kaur C, Hardeland R, Cardinali DP (2013) Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. Neurotox Res 23(3):267\u2013300. https:\/\/doi.org\/10.1007\/s12640-012-9337-4","journal-title":"Neurotox Res"},{"issue":"2","key":"2939_CR179","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1074248416660622","volume":"22","author":"SR Pandi-Perumal","year":"2016","unstructured":"Pandi-Perumal SR, BaHammam AS, Ojike NI, Akinseye OA, Kendzerska T, Buttoo K, Cardinali DP (2016) Melatonin and human cardiovascular disease. J Cardiovasc Pharmacol Therap 22(2):122\u2013132. https:\/\/doi.org\/10.1177\/1074248416660622","journal-title":"J Cardiovasc Pharmacol Therap"},{"key":"2939_CR180","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2019\/9626715","volume":"2019","author":"J Paprocka","year":"2019","unstructured":"Paprocka J, Kijonka M, Rzepka B, Sok\u00f3\u0142 M (2019) Melatonin in hypoxic-ischemic brain injury in term and preterm babies. Int J Endocrinol 2019:11. https:\/\/doi.org\/10.1155\/2019\/9626715","journal-title":"Int J Endocrinol"},{"issue":"4","key":"2939_CR181","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.pbb.2011.06.026","volume":"99","author":"G Patki","year":"2011","unstructured":"Patki G, Lau YS (2011) Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of parkinson\u2019s disease. Pharmacol Biochem Behav 99(4):704\u2013711. https:\/\/doi.org\/10.1016\/j.pbb.2011.06.026","journal-title":"Pharmacol Biochem Behav"},{"key":"2939_CR182","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.lfs.2017.11.016","volume":"192","author":"R Paul","year":"2018","unstructured":"Paul R, Phukan BC, Justin Thenmozhi A, Manivasagam T, Bhattacharya P, Borah A (2018) Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of parkinson\u2019s disease. Life Sci 192:238\u2013245. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.016","journal-title":"Life Sci"},{"key":"2939_CR183","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.phrs.2018.01.018","volume":"130","author":"S Peineau","year":"2018","unstructured":"Peineau S, Rabiant K, Pierrefiche O, Potier B (2018) Synaptic plasticity modulation by circulating peptides and metaplasticity: involvement in alzheimer\u2019s disease. Pharmacol Res 130:385\u2013401. https:\/\/doi.org\/10.1016\/j.phrs.2018.01.018","journal-title":"Pharmacol Res"},{"issue":"6","key":"2939_CR184","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.neurobiolaging.2012.12.010","volume":"34","author":"CX Peng","year":"2013","unstructured":"Peng CX, Hu J, Liu D, Hong XP, Wu YY, Zhu LQ, Wang JZ (2013) Disease-modified glycogen synthase kinase-3\u03b2 intervention by melatonin arrests the pathology and memory deficits in an alzheimer\u2019s animal model. Neurobiol Aging 34(6):1555\u20131563. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.12.010","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2939_CR185","doi-asserted-by":"publisher","first-page":"e12699","DOI":"10.1111\/jpi.12699","volume":"70","author":"L Pham","year":"2021","unstructured":"Pham L, Baiocchi L, Kennedy L, Sato K, Meadows V, Meng F, Huang CK, Kundu D, Zhou T, Chen L, Alpini G, Francis H (2021) The interplay between mast cells, pineal gland, and circadian rhythm: links between histamine, melatonin, and inflammatory mediators. J Pineal Res 70(2):e12699. https:\/\/doi.org\/10.1111\/jpi.12699","journal-title":"J Pineal Res"},{"issue":"1","key":"2939_CR186","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrneurol.2017.162","volume":"14","author":"JC Polanco","year":"2018","unstructured":"Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, G\u00f6tz J (2018) Amyloid-\u03b2 and tau complexity\u2014towards improved biomarkers and targeted therapies. Nat Rev Neurol 14(1):22\u201339. https:\/\/doi.org\/10.1038\/nrneurol.2017.162","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2939_CR187","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10522-023-10034-1","volume":"24","author":"A Prajapati","year":"2023","unstructured":"Prajapati A, Mehan S, Khan Z (2023) The role of smo-shh\/gli signaling activation in the prevention of neurological and ageing disorders. Biogerontology 24(4):493\u2013531. https:\/\/doi.org\/10.1007\/s10522-023-10034-1","journal-title":"Biogerontology"},{"key":"2939_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10715762.2020.1774575","volume":"54","author":"A Purushothaman","year":"2020","unstructured":"Purushothaman A, Sheeja AA, Janardanan D (2020) Hydroxyl radical scavenging activity of melatonin and its related indolamines. Free Radic Res 54:1\u201311. https:\/\/doi.org\/10.1080\/10715762.2020.1774575","journal-title":"Free Radic Res"},{"issue":"9","key":"2939_CR189","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41440-018-0066-9","volume":"41","author":"F Qiu","year":"2018","unstructured":"Qiu F, Liu X, Zhang Y, Wu Y, Xiao D, Shi L (2018) Aerobic exercise enhanced endothelium-dependent vasorelaxation in mesenteric arteries in spontaneously hypertensive rats: the role of melatonin. Hypertens Res Off J Japan Soc Hypertens 41(9):718\u2013729. https:\/\/doi.org\/10.1038\/s41440-018-0066-9","journal-title":"Hypertens Res Off J Japan Soc Hypertens"},{"issue":"11","key":"2939_CR190","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1177\/09603271211013456","volume":"40","author":"S Rahi","year":"2021","unstructured":"Rahi S, Gupta R, Sharma A, Mehan S (2021) Smo-shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism. Human Exper Toxicol 40(11):1880\u20131898. https:\/\/doi.org\/10.1177\/09603271211013456","journal-title":"Human Exper Toxicol"},{"issue":"8","key":"2939_CR191","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/ph15080959","volume":"15","author":"B Rajkhowa","year":"2022","unstructured":"Rajkhowa B, Mehan S, Sethi P, Prajapati A, Suri M, Kumar S, Bhalla S, Narula AS, Alshammari A, Alharbi M, Alkahtani N, Alghamdi S, Kalfin R (2022) Activating SIRT-1 signalling with the mitochondrial-CoQ10 activator solanesol improves neurobehavioral and neurochemical defects in ouabain-induced experimental model of bipolar disorder. Pharmaceuticals (Basel, Switzerland) 15(8):959. https:\/\/doi.org\/10.3390\/ph15080959","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"7","key":"2939_CR192","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/cells8070760","volume":"8","author":"S Rehman","year":"2019","unstructured":"Rehman S, Ikram M, Ullah N, Alam S, Park H, Badshah H, Ok Kim M (2019) Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK\/CREB signaling. Cells 8(7):760. https:\/\/doi.org\/10.3390\/cells8070760","journal-title":"Cells"},{"key":"2939_CR193","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.comptc.2017.11.017","volume":"1123","author":"M Reina","year":"2018","unstructured":"Reina M, Mart\u00ednez A (2018) A new free radical scavenging cascade involving melatonin and three of its metabolites (3OHM, AFMK and AMK). Comput Theoretic Chem 1123:111\u2013118. https:\/\/doi.org\/10.1016\/j.comptc.2017.11.017","journal-title":"Comput Theoretic Chem"},{"issue":"3","key":"2939_CR194","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jpi.12360","volume":"61","author":"RJ Reiter","year":"2016","unstructured":"Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L (2016) Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61(3):253\u2013278. https:\/\/doi.org\/10.1111\/jpi.12360","journal-title":"J Pineal Res"},{"issue":"2","key":"2939_CR195","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/molecules23020509","volume":"23","author":"R Reiter","year":"2018","unstructured":"Reiter R, Tan D, Rosales-Corral S, Galano A, Zhou X, Xu B (2018) Mitochondria: central organelles for melatonin\u2032s antioxidant and anti-aging actions. Molecules 23(2):509. https:\/\/doi.org\/10.3390\/molecules23020509","journal-title":"Molecules"},{"key":"2939_CR196","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2022.03.025","volume":"605","author":"RJ Reiter","year":"2022","unstructured":"Reiter RJ, Sharma R, Rosales-Corral S, de Mange J, Phillips WT, Tan DX, Bitar RD (2022) Melatonin in ventricular and subarachnoid cerebrospinal fluid: its function in the neural glymphatic network and biological significance for neurocognitive health. Biochem Biophys Res Communic 605:70\u201381. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.025","journal-title":"Biochem Biophys Res Communic"},{"issue":"3","key":"2939_CR197","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.pcl.2011.03.009","volume":"58","author":"AM Reynolds","year":"2011","unstructured":"Reynolds AM, Malow BA (2011) Sleep and autism spectrum disorders. Pediatr Clin North Am 58(3):685\u2013698. https:\/\/doi.org\/10.1016\/j.pcl.2011.03.009","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"2939_CR198","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.3390\/ijms14046597","volume":"14","author":"C Rodriguez","year":"2013","unstructured":"Rodriguez C, Mart\u00edn V, Herrera F, Garc\u00eda-Santos G, Rodriguez-Blanco J, Casado-Zapico S, S\u00e1nchez-S\u00e1nchez AM, Su\u00e1rez S, Puente-Moncada N, An\u00edtua MJ, Antol\u00edn I (2013) Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int J Mol Sci 14(4):6597\u20136613. https:\/\/doi.org\/10.3390\/ijms14046597","journal-title":"Int J Mol Sci"},{"key":"2939_CR199","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/b978-0-12-405933-7.00018-4","volume":"2014","author":"SA Rosales-Corral","year":"2014","unstructured":"Rosales-Corral SA, Reiter RJ, Tan D-X, Manchester LC, Liu X (2014) Antioxidant and anti-inflammatory role of melatonin in alzheimer\u2019s neurodegeneration. Aging 2014:177\u2013193. https:\/\/doi.org\/10.1016\/b978-0-12-405933-7.00018-4","journal-title":"Aging"},{"issue":"1","key":"2939_CR200","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"issue":"13","key":"2939_CR201","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.3390\/ijms22136841","volume":"22","author":"J Roy","year":"2021","unstructured":"Roy J, Tsui KC, Ng J, Fung ML, Lim LW (2021) Regulation of melatonin and neurotransmission in alzheimer\u2019s disease. Int J Mol Sci 22(13):6841. https:\/\/doi.org\/10.3390\/ijms22136841","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2939_CR202","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2174\/1381612822666151214104624","volume":"22","author":"L Sagrillo-Fagundes","year":"2016","unstructured":"Sagrillo-Fagundes L, Assun\u00e7\u00e3o Salustiano EM, Yen PW, Soliman A, Vaillancourt C (2016) Melatonin in pregnancy: effects on brain development and CNS programming disorders. Curr Pharm Des 22(8):978\u2013986. https:\/\/doi.org\/10.2174\/1381612822666151214104624","journal-title":"Curr Pharm Des"},{"issue":"6","key":"2939_CR203","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/13543784.2012.681045","volume":"21","author":"EJ Sanchez-Barcelo","year":"2012","unstructured":"Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, Reiter RJ (2012) Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Invest Drugs 21(6):819\u2013831. https:\/\/doi.org\/10.1517\/13543784.2012.681045","journal-title":"Expert Opin Invest Drugs"},{"issue":"1","key":"2939_CR204","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1254\/jphs.13r01sr","volume":"123","author":"G Sarlak","year":"2013","unstructured":"Sarlak G, Jenwitheesuk A, Chetsawang B, Govitrapong P (2013) Effects of melatonin on nervous system aging: neurogenesis and neurodegeneration. J Pharmacol Sci 123(1):9\u201324. https:\/\/doi.org\/10.1254\/jphs.13r01sr","journal-title":"J Pharmacol Sci"},{"issue":"11","key":"2939_CR205","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/gerona\/glz079","volume":"74","author":"R Sayed","year":"2019","unstructured":"Sayed R, Fern\u00e1ndez-Ortiz M, Diaz-Casado ME, Aranda-Mart\u00ednez P, Fern\u00e1ndez-Mart\u00ednez J, Guerra-Librero A, Escames G, L\u00f3pez LC, Alsaadawy RM, Acu\u00f1a-Castroviejo D (2019) Lack of NLRP3 inflammasome activation reduces age-dependent sarcopenia and mitochondrial dysfunction, favoring the prophylactic effect of melatonin. the journals of gerontology. Series Biol Sci Med Sci 74(11):1699\u20131708. https:\/\/doi.org\/10.1093\/gerona\/glz079","journal-title":"Series Biol Sci Med Sci"},{"issue":"23","key":"2939_CR206","doi-asserted-by":"publisher","first-page":"00103","DOI":"10.1016\/j.neuro.2023.08.001","volume":"S0161-813X","author":"P Sethi","year":"2023","unstructured":"Sethi P, Mehan S, Khan Z, Chhabra S (2023) Acetyl-11-keto-Beta boswellic ACID(AKBA) modulates CSTC-pathway by activating SIRT-1\/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: evidenced by CSF, blood plasma and histopathological alterations. Neurotoxicology S0161-813X(23):00103\u20131. https:\/\/doi.org\/10.1016\/j.neuro.2023.08.001. (Advance online publication)","journal-title":"Neurotoxicology"},{"key":"2939_CR207","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.toxrep.2019.10.019","volume":"6","author":"R Sharma","year":"2019","unstructured":"Sharma R, Rahi S, Mehan S (2019) Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: insights from behavioral and biochemical evidence. Toxicol Rep 6:1164\u20131175. https:\/\/doi.org\/10.1016\/j.toxrep.2019.10.019","journal-title":"Toxicol Rep"},{"issue":"4","key":"2939_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100051","volume":"1","author":"N Sharma","year":"2021","unstructured":"Sharma N, Upadhayay S, Shandilya A, Sahu R, Singh A, Rajkhowa B, Mehan S (2021) Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats. Phytomedicine Plus 1(4):100051. https:\/\/doi.org\/10.1016\/j.phyplu.2021.100051","journal-title":"Phytomedicine Plus"},{"issue":"5\u20136","key":"2939_CR209","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000454681","volume":"23","author":"D Shen","year":"2016","unstructured":"Shen D, Tian X, Sang W, Song R (2016) Effect of melatonin and resveratrol against memory impairment and hippocampal damage in a rat model of vascular dementia. Neuroimmunomodulation 23(5\u20136):318\u2013331. https:\/\/doi.org\/10.1159\/000454681","journal-title":"Neuroimmunomodulation"},{"key":"2939_CR210","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1007\/s12035-022-02875-7","volume":"59","author":"X Shen","year":"2022","unstructured":"Shen X, Tang C, Wei C et al (2022) Melatonin induces autophagy in amyotrophic lateral sclerosis mice via upregulation of SIRT1. Mol Neurobiol 59:4747\u20134760. https:\/\/doi.org\/10.1007\/s12035-022-02875-7","journal-title":"Mol Neurobiol"},{"key":"2939_CR211","doi-asserted-by":"publisher","first-page":"114083","DOI":"10.1016\/j.bbr.2022.114083","volume":"436","author":"N Shokri-Mashhadi","year":"2023","unstructured":"Shokri-Mashhadi N et al (2023) Effects of melatonin supplementation on BDNF concentrations and depression: a systematic review and meta-analysis of randomized controlled trials. Behav Brain Res 436:114083. https:\/\/doi.org\/10.1016\/j.bbr.2022.114083","journal-title":"Behav Brain Res"},{"key":"2939_CR212","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14005","author":"M Shukla","year":"2019","unstructured":"Shukla M, Chinchalongporn V, Govitrapong P, Reiter RJ (2019) The role of melatonin in targeting cell signaling pathways in neurodegeneration. Annals of the New York Academy of Sciences. https:\/\/doi.org\/10.1111\/nyas.14005","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"2939_CR213","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","volume":"50","author":"NK Singhal","year":"2011","unstructured":"Singhal NK, Srivastava G, Patel DK, Jain SK, Singh MP (2011) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson\u2019s disease phenotype in the mouse. J Pineal Res 50(2):97\u2013109. https:\/\/doi.org\/10.1111\/j.1600-079X.2010.00819.x","journal-title":"J Pineal Res"},{"issue":"2","key":"2939_CR214","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.mce.2012.01.004","volume":"351","author":"RM Slominski","year":"2012","unstructured":"Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT (2012) Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 351(2):152\u2013166. https:\/\/doi.org\/10.1016\/j.mce.2012.01.004","journal-title":"Mol Cell Endocrinol"},{"key":"2939_CR215","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bbr.2014.06.030","volume":"271","author":"LC Souza","year":"2014","unstructured":"Souza LC, Wilhelm EA, Bortolatto CF, Nogueira CW, Boeira SP, Jesse CR (2014) The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain. Behav Brain Res 271:316\u2013324. https:\/\/doi.org\/10.1016\/j.bbr.2014.06.030","journal-title":"Behav Brain Res"},{"issue":"4","key":"2939_CR216","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF03033887","volume":"7","author":"V Srinivasan","year":"2005","unstructured":"Srinivasan V, Pandi-Perumal SR, Maestroni GJ, Esquifino AI, Hardeland R, Cardinali DP (2005) Role of melatonin in neurodegenerative diseases. Neurotox Res 7(4):293\u2013318. https:\/\/doi.org\/10.1007\/BF03033887","journal-title":"Neurotox Res"},{"key":"2939_CR217","doi-asserted-by":"publisher","first-page":"784314","DOI":"10.2147\/cpt.s44802","volume":"51","author":"V Srinivasan","year":"2014","unstructured":"Srinivasan V, Dominico DB, Partonen T, Othman Z, Zakaria R (2014) The use of melatonin for treating sleep disorders in patients with parkinson\u2019s disease. ChronoPhysiol Ther 51:784314. https:\/\/doi.org\/10.2147\/cpt.s44802","journal-title":"ChronoPhysiol Ther"},{"issue":"2","key":"2939_CR218","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/diagnostics11020231","volume":"11","author":"I \u0160t\u011btk\u00e1\u0159ov\u00e1","year":"2021","unstructured":"\u0160t\u011btk\u00e1\u0159ov\u00e1 I, Ehler E (2021) Diagnostics of amyotrophic lateral sclerosis: up to date. Diagnostics (Basel, Switzerland) 11(2):231. https:\/\/doi.org\/10.3390\/diagnostics11020231","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"2939_CR219","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.neubiorev.2021.04.034","volume":"127","author":"DM Sumsuzzman","year":"2021","unstructured":"Sumsuzzman DM, Choi J, Jin Y, Hong Y (2021) Neurocognitive effects of melatonin treatment in healthy adults and individuals with alzheimer\u2019s disease and insomnia: a systematic review and meta-analysis of randomized controlled trials. Neurosci Biobehav Rev 127:459\u2013473. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.04.034","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"2939_CR220","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.3892\/mmr.2016.4991","volume":"13","author":"X Sun","year":"2016","unstructured":"Sun X, Ran D, Zhao X, Huang Y, Long S, Liang F, Guo W, Nucifora FC Jr, Gu H, Lu X, Chen L, Zeng J, Ross CA, Pei Z (2016) Melatonin attenuates hLRRK2-induced sleep disturbances and synaptic dysfunction in a drosophila model of parkinson\u2019s disease. Mol Med Rep 13(5):3936\u20133944. https:\/\/doi.org\/10.3892\/mmr.2016.4991","journal-title":"Mol Med Rep"},{"issue":"10","key":"2939_CR221","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3390\/antiox10101528","volume":"10","author":"S Taherkhani","year":"2021","unstructured":"Taherkhani S, Valaei K, Arazi H, Suzuki K (2021) An overview of physical exercise and antioxidant supplementation influences on skeletal muscle oxidative stress. Antioxidants (Basel, Switzerland) 10(10):1528. https:\/\/doi.org\/10.3390\/antiox10101528","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1","key":"2939_CR222","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1600-079X.2006.00407.x","volume":"42","author":"DX Tan","year":"2007","unstructured":"Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2007) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42(1):28\u201342. https:\/\/doi.org\/10.1111\/j.1600-079X.2006.00407.x","journal-title":"J Pineal Res"},{"issue":"12","key":"2939_CR223","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/ijms17122124","volume":"17","author":"D-X Tan","year":"2016","unstructured":"Tan D-X, Manchester L, Qin L, Reiter R (2016) Melatonin: a mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int J Mol Sci 17(12):2124. https:\/\/doi.org\/10.3390\/ijms17122124","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2939_CR224","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/molecules23020301","volume":"23","author":"DX Tan","year":"2018","unstructured":"Tan DX, Xu B, Zhou X, Reiter RJ (2018) Pineal calcification, melatonin production, aging, associated health consequences and rejuvenation of the pineal gland. Molecules (Basel, Switzerland) 23(2):301. https:\/\/doi.org\/10.3390\/molecules23020301","journal-title":"Molecules (Basel, Switzerland)"},{"key":"2939_CR225","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.physbeh.2018.02.034","volume":"188","author":"EH Taniguti","year":"2018","unstructured":"Taniguti EH, Ferreira YS, Stupp IJV, Fraga-Junior EB, Mendon\u00e7a CB, Rossi FL, Vandresen-Filho S (2018) Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice. Physiol Beh 188:270\u2013275. https:\/\/doi.org\/10.1016\/j.physbeh.2018.02.034","journal-title":"Physiol Beh"},{"issue":"11","key":"2939_CR226","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu AG, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM (2022) Neurotransmitters\u2014key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci 23(11):5954. https:\/\/doi.org\/10.3390\/ijms23115954","journal-title":"Int J Mol Sci"},{"key":"2939_CR227","doi-asserted-by":"publisher","first-page":"114980","DOI":"10.1016\/j.bcp.2022.114980","volume":"198","author":"P Thangwong","year":"2022","unstructured":"Thangwong P, Jearjaroen P, Govitrapong P, Tocharus C, Tocharus J (2022) Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats. Biochem Pharmacol 198:114980. https:\/\/doi.org\/10.1016\/j.bcp.2022.114980","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2939_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpi.12081","volume":"56","author":"Y Tian","year":"2014","unstructured":"Tian Y, Yabuki Y, Moriguchi S, Fukunaga K, Mao PJ, Hong LJ, Lu YM, Wang R, Ahmed MM, Liao MH, Huang JY, Zhang RT, Zhou TY, Long S, Han F (2014) Melatonin reverses the decreases in hippocampal protein serine\/threonine kinases observed in an animal model of autism. J Pineal Res 56(1):1\u201311. https:\/\/doi.org\/10.1111\/jpi.12081","journal-title":"J Pineal Res"},{"issue":"9","key":"2939_CR229","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2174\/1389450121666201020155010","volume":"22","author":"A Tiwari","year":"2021","unstructured":"Tiwari A, Rahi S, Mehan S (2021) Elucidation of abnormal extracellular regulated kinase (ERK) signaling and associations with syndromic and non-syndromic autism. Curr Drug Targets 22(9):1071\u20131086. https:\/\/doi.org\/10.2174\/1389450121666201020155010","journal-title":"Curr Drug Targets"},{"issue":"3","key":"2939_CR230","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/1570159x1466616122812","volume":"15","author":"S Tordjman","year":"2017","unstructured":"Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C (2017) Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol 15(3):434\u2013443. https:\/\/doi.org\/10.2174\/1570159x1466616122812","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"2939_CR231","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11910-016-0664-3","volume":"16","author":"LM Trotti","year":"2016","unstructured":"Trotti LM, Karroum EG (2016) Melatonin for sleep disorders in patients with neurodegenerative diseases. Curr Neurol Neurosci Rep 16(7):63. https:\/\/doi.org\/10.1007\/s11910-016-0664-3","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"38","key":"2939_CR232","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.18632\/oncotarget.27754","volume":"11","author":"TH Tsai","year":"2020","unstructured":"Tsai TH, Lin CJ, Chua S, Chung SY, Yang CH, Tong MS, Hang CL (2020) Correction: melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion. Oncotarget 11(38):3558. https:\/\/doi.org\/10.18632\/oncotarget.27754","journal-title":"Oncotarget"},{"issue":"4","key":"2939_CR233","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11357-017-9981-y","volume":"39","author":"Z Tucsek","year":"2017","unstructured":"Tucsek Z, Noa Valcarcel-Ares M, Tarantini S, Yabluchanskiy A, F\u00fcl\u00f6p G, Gautam T, Orock A, Csiszar A, Deak F, Ungvari Z (2017) Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment. GeroScience 39(4):385\u2013406. https:\/\/doi.org\/10.1007\/s11357-017-9981-y","journal-title":"GeroScience"},{"key":"2939_CR234","doi-asserted-by":"publisher","first-page":"04","DOI":"10.3389\/fnagi.2018.00004","volume":"10","author":"MS Uddin","year":"2018","unstructured":"Uddin MS, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG, Bergantin LB, Abdel-Daim MM, Stankiewicz AM (2018) Autophagy and alzheimer\u2019s disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci 10:04. https:\/\/doi.org\/10.3389\/fnagi.2018.00004","journal-title":"Front Aging Neurosci"},{"issue":"20","key":"2939_CR235","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.2174\/0929867323666160428105849","volume":"23","author":"AC Uguz","year":"2016","unstructured":"Uguz AC, Demirci K, Espino J (2016) The importance of melatonin and mitochondria interaction in mood disorders and schizophrenia: a current assessment. Curr Med Chem 23(20):2146\u20132158. https:\/\/doi.org\/10.2174\/0929867323666160428105849","journal-title":"Curr Med Chem"},{"issue":"8","key":"2939_CR236","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/genes13081324","volume":"13","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, Almashjary MN, Tabrez S (2022) Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes 13(8):1324. https:\/\/doi.org\/10.3390\/genes13081324","journal-title":"Genes"},{"issue":"23","key":"2939_CR237","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.3390\/ijms20236004","volume":"20","author":"RP Ureshino","year":"2019","unstructured":"Ureshino RP, Erustes AG, Bassani TB, Wachilewski P, Guarache GC, Nascimento AJ, Pereira GJ (2019) The interplay between Ca2+ signaling pathways and neurodegeneration. Int J Mol Sci 20(23):6004. https:\/\/doi.org\/10.3390\/ijms20236004","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2939_CR238","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1007\/s12035-015-9404-y","volume":"53","author":"G Vakilzadeh","year":"2015","unstructured":"Vakilzadeh G, Khodagholi F, Ghadiri T, Ghaemi A, Noorbakhsh F, Sharifzadeh M, Gorji A (2015) The effect of melatonin on behavioral, molecular, and histopathological changes in cuprizone model of demyelination. Mol Neurobiol 53(7):4675\u20134684. https:\/\/doi.org\/10.1007\/s12035-015-9404-y","journal-title":"Mol Neurobiol"},{"issue":"16","key":"2939_CR239","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1111\/bph.14197","volume":"175","author":"M Vald\u00e9s-Tovar","year":"2018","unstructured":"Vald\u00e9s-Tovar M, Estrada-Reyes R, Sol\u00eds-Chagoy\u00e1n H, Argueta J, Dorantes-Barr\u00f3n AM, Quero-Ch\u00e1vez D, Cruz-Gardu\u00f1o R, Cerc\u00f3s MG, Trueta C, Oikawa-Sala J, Dubocovich ML, Ben\u00edtez-King G (2018) Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression. Bri J Pharmacol 175(16):3200\u20133208. https:\/\/doi.org\/10.1111\/bph.14197","journal-title":"Bri J Pharmacol"},{"key":"2939_CR240","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.psychres.2018.03.089","volume":"264","author":"SS Valvassori","year":"2018","unstructured":"Valvassori SS, Bavaresco DV, Feier G, Cechinel-Recco K, Steckert AV, Varela RB, Borges C, Carvalho-Silva M, Gomes LM, Streck EL, Quevedo J (2018) Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes. Psychiatry Res 264:192\u2013201. https:\/\/doi.org\/10.1016\/j.psychres.2018.03.089","journal-title":"Psychiatry Res"},{"issue":"11","key":"2939_CR241","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3390\/ijms20112818","volume":"20","author":"MAJ Van den Bos","year":"2019","unstructured":"Van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S (2019) Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques. Int J Mol Sci 20(11):2818. https:\/\/doi.org\/10.3390\/ijms20112818","journal-title":"Int J Mol Sci"},{"key":"2939_CR242","doi-asserted-by":"publisher","unstructured":"Vecchierini MF, Kilic-Huck U, Quera-Salva MA, Members of the MEL consensus group of the SFRMS (2021) Melatonin (MEL) and its use in neurological diseases and insomnia: recommendations of the French Medical and Research Sleep Society (SFRMS).\u00a0Revue Neurologique,\u00a0177(3), 245\u2013259. https:\/\/doi.org\/10.1016\/j.neurol.2020.06.009","DOI":"10.1016\/j.neurol.2020.06.009"},{"key":"2939_CR243","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","volume":"71","author":"A Videnovic","year":"2014","unstructured":"Videnovic A, Noble C, Reid KJ et al (2014) Circadian melatonin rhythm and excessive daytime sleepiness in parkinson disease. J Am Med Assoc Neurol 71:463\u2013469. https:\/\/doi.org\/10.1001\/jamaneurol.2013.6239","journal-title":"J Am Med Assoc Neurol"},{"key":"2939_CR244","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","volume":"4","author":"E Vieta","year":"2018","unstructured":"Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, Gao K, Miskowiak KW, Grande I (2018) Bipolar disorders. Nat Rev Dis Prime 4:18008. https:\/\/doi.org\/10.1038\/nrdp.2018.8","journal-title":"Nat Rev Dis Prime"},{"key":"2939_CR245","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.phrs.2018.06.011","volume":"134","author":"B Vincent","year":"2018","unstructured":"Vincent B (2018) Protective roles of melatonin against the amyloid-dependent development of alzheimer\u2019s disease: a critical review. Pharmacol Rres 134:223\u2013237. https:\/\/doi.org\/10.1016\/j.phrs.2018.06.011","journal-title":"Pharmacol Rres"},{"issue":"4","key":"2939_CR246","first-page":"488","volume":"7","author":"SE Voiculescu","year":"2014","unstructured":"Voiculescu SE, Zygouropoulos N, Zahiu CD, Zagrean AM (2014) Role of melatonin in embryo fetal development. J Med Life 7(4):488\u2013492","journal-title":"J Med Life"},{"key":"2939_CR247","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s00018-014-1659-3","volume":"71","author":"J Vriend","year":"2014","unstructured":"Vriend J, Reiter RJ (2014) Melatonin and ubiquitin: what\u2019s the connection? Cell Mol Life Scie 71:3409\u20133418. https:\/\/doi.org\/10.1007\/s00018-014-1659-3","journal-title":"Cell Mol Life Scie"},{"issue":"1","key":"2939_CR248","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-079X.2004.00130.x","volume":"37","author":"DL Wang","year":"2004","unstructured":"Wang DL, Ling ZQ, Cao FY, Zhu LQ, Wang JZ (2004) Melatonin attenuates isoproterenol-induced protein kinase a overactivation and tau hyperphosphorylation in rat brain. J Pineal Res 37(1):11\u201316. https:\/\/doi.org\/10.1111\/j.1600-079X.2004.00130.x","journal-title":"J Pineal Res"},{"issue":"8","key":"2939_CR249","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s11064-007-9308-y","volume":"32","author":"S Wang","year":"2007","unstructured":"Wang S, Zhu L, Shi H, Zheng H, Tian Q, Wang Q, Liu R, Wang JZ (2007) Inhibition of melatonin biosynthesis induces neurofilament hyperphosphorylation with activation of cyclin-dependent kinase 5. Neurochem Res 32(8):1329\u20131335. https:\/\/doi.org\/10.1007\/s11064-007-9308-y","journal-title":"Neurochem Res"},{"issue":"1","key":"2939_CR250","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/gps.4571","volume":"32","author":"YY Wang","year":"2017","unstructured":"Wang YY, Zheng W, Ng CH, Ungvari GS, Wei W, Xiang YT (2017) Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in alzheimer\u2019s disease. Int J Geriatr Psychiatry 32(1):50\u201357. https:\/\/doi.org\/10.1002\/gps.4571","journal-title":"Int J Geriatr Psychiatry"},{"issue":"8","key":"2939_CR251","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.26355\/eurrev_201904_17723","volume":"23","author":"CF Wang","year":"2019","unstructured":"Wang CF, Song CY, Wang X, Huang LY, Ding M, Yang H, Wang P, Xu LL, Xie ZH, Bi JZ (2019) Protective effects of melatonin on mitochondrial biogenesis and mitochondrial structure and function in the HEK293-APPswe cell model of alzheimer\u2019s disease. Eur Rev Medic Pharmacol Sci 23(8):3542\u20133550. https:\/\/doi.org\/10.26355\/eurrev_201904_17723","journal-title":"Eur Rev Medic Pharmacol Sci"},{"issue":"1","key":"2939_CR252","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X (2020) Mitochondria dysfunction in the pathogenesis of alzheimer\u2019s disease: recent advances. Mol Neurodegen 15(1):30. https:\/\/doi.org\/10.1186\/s13024-020-00376-6","journal-title":"Mol Neurodegen"},{"issue":"1","key":"2939_CR253","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/WNR.0000000000001554","volume":"32","author":"S Wang","year":"2021","unstructured":"Wang S, Xu X, Ju X, Wang S, Li J, Yan P, Yu Z, Song M (2021) Melatonin ameliorated CUMS-induced depression-like behavior via restoring endoplasmic reticulum stress in rat hippocampus. Neuroreport 32(1):8\u201315. https:\/\/doi.org\/10.1097\/WNR.0000000000001554","journal-title":"Neuroreport"},{"key":"2939_CR254","doi-asserted-by":"publisher","first-page":"113724","DOI":"10.1016\/j.bbr.2021.113724","volume":"420","author":"YQ Wang","year":"2022","unstructured":"Wang YQ, Jiang YJ, Zou MS, Liu J, Zhao HQ, Wang YH (2022) Antidepressant actions of melatonin and melatonin receptor agonist: focus on pathophysiology and treatment. Behav Brain Res 420:113724. https:\/\/doi.org\/10.1016\/j.bbr.2021.113724","journal-title":"Behav Brain Res"},{"issue":"4","key":"2939_CR255","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-079X.2006.00377.x","volume":"41","author":"JH Weishaupt","year":"2006","unstructured":"Weishaupt JH, Bartels C, P\u00f6lking E, Dietrich J, Rohde G, Poeggeler B, Mertens N, Sperling S, Bohn M, H\u00fcther G, Schneider A, Bach A, Sir\u00e9n AL, Hardeland R, B\u00e4hr M, Nave KA, Ehrenreich H (2006) Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res 41(4):313\u2013323. https:\/\/doi.org\/10.1111\/j.1600-079X.2006.00377.x","journal-title":"J Pineal Res"},{"issue":"8","key":"2939_CR256","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.2174\/1381612822666151214125657","volume":"22","author":"P Wongprayoon","year":"2016","unstructured":"Wongprayoon P, Govitrapong P (2016) Melatonin attenuates methamphetamine-induced neurotoxicity. Curr Pharm Des 22(8):1022\u20131032. https:\/\/doi.org\/10.2174\/1381612822666151214125657","journal-title":"Curr Pharm Des"},{"key":"2939_CR257","unstructured":"World Health Organization. The Ten Top Causes of Death. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death#:~:text=The%20top%20global%20causes%20of,birth%20asphyxia%20and%20birth%20trauma%2C. Accessed 9 Dec 2020"},{"issue":"4","key":"2939_CR258","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1192\/bjp.bp.111.096321","volume":"200","author":"K Wulff","year":"2012","unstructured":"Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM (2012) Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry J Mental Sci 200(4):308\u2013316. https:\/\/doi.org\/10.1192\/bjp.bp.111.096321","journal-title":"Br J Psychiatry J Mental Sci"},{"key":"2939_CR259","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.nlm.2013.11.016(RetractionpublishedNeurobiolLearnMem.2015Dec;126:87)","volume":"109","author":"Y Xi","year":"2014","unstructured":"Xi Y, Wang M, Zhang W, Bai M, Du Y, Zhang Z, Li Z, Miao J (2014) Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion. Neurobiol Learn Mem 109:7\u201319. https:\/\/doi.org\/10.1016\/j.nlm.2013.11.016(RetractionpublishedNeurobiolLearnMem.2015Dec;126:87)","journal-title":"Neurobiol Learn Mem"},{"key":"2939_CR260","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnmol.2017.00049","volume":"10","author":"F Xue","year":"2017","unstructured":"Xue F, Shi C, Chen Q, Hang W, Xia L, Wu Y, Chen J (2017) Melatonin mediates protective effects against kainic acid-induced neuronal death through safeguarding ER stress and mitochondrial disturbance. Front Mol Neurosci 10:49. https:\/\/doi.org\/10.3389\/fnmol.2017.00049","journal-title":"Front Mol Neurosci"},{"key":"2939_CR261","doi-asserted-by":"publisher","first-page":"960327122108427","DOI":"10.1177\/09603271221084276","volume":"41","author":"RK Yadav","year":"2022","unstructured":"Yadav RK, Mehan S, Sahu R, Kumar S, Khan A, Makeen HA, Al Bratty M (2022) Protective effects of apigenin on methylmercury-induced behavioral\/neurochemical abnormalities and neurotoxicity in rats. Human Exper Toxicol 41:9603271221084276. https:\/\/doi.org\/10.1177\/09603271221084276","journal-title":"Human Exper Toxicol"},{"issue":"2","key":"2939_CR262","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2012.04.033","volume":"53","author":"T Yamamori","year":"2012","unstructured":"Yamamori T, Yasui H, Yamazumi M, Wada Y, Nakamura Y, Nakamura H, Inanami O (2012) Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. Free radical biology & medicine 53(2):260\u2013270. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.04.033","journal-title":"Free radical biology & medicine"},{"issue":"1","key":"2939_CR263","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jpi.12193","volume":"58","author":"Y Yang","year":"2015","unstructured":"Yang Y, Jiang S, Dong Y, Fan C, Zhao L, Yang X, Li J, Di S, Yue L, Liang G, Reiter RJ, Qu Y (2015) Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice. J Pineal Res 58(1):61\u201370. https:\/\/doi.org\/10.1111\/jpi.12193","journal-title":"J Pineal Res"},{"issue":"4","key":"2939_CR264","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/life12040574","volume":"12","author":"H Yapislar","year":"2022","unstructured":"Yapislar H, Haciosmanoglu E, Sarioglu T, Degirmencioglu S, Sogut I, Poteser M, Ekmekcioglu C (2022) Anti-inflammatory effects of melatonin in rats with induced type 2 diabetes mellitus. Life. 12(4):574. https:\/\/doi.org\/10.3390\/life12040574","journal-title":"Life."},{"issue":"12","key":"2939_CR265","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397.PMID:32165850;PMCID:PMC7050025","volume":"29","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in alzheimer disease: an update. J Cent Nerv Syst Dis. 29(12):1179573520907397. https:\/\/doi.org\/10.1177\/1179573520907397.PMID:32165850;PMCID:PMC7050025","journal-title":"J Cent Nerv Syst Dis."},{"issue":"8","key":"2939_CR266","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/jpc.12868","volume":"51","author":"EM Yiu","year":"2015","unstructured":"Yiu EM, Kornberg AJ (2015) Duchenne muscular dystrophy. J Paediatr child Health 51(8):759\u2013764. https:\/\/doi.org\/10.1111\/jpc.12868","journal-title":"J Paediatr child Health"},{"key":"2939_CR267","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mad.2016.02.003","volume":"155","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Fernandes CV, Philip N, Jingqiu C, Younan C, Yanrong L (2016) Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis. Mechan Age Devel 155:10\u201321. https:\/\/doi.org\/10.1016\/j.mad.2016.02.003","journal-title":"Mechan Age Devel"},{"issue":"4","key":"2939_CR268","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4062\/biomolther.2017.071","volume":"26","author":"SP Yun","year":"2018","unstructured":"Yun SP, Han YS, Lee JH, Kim SM, Lee SH (2018) Melatonin rescues mesenchymal stem cells from senescence induced by the uremic toxin p-cresol via inhibiting mTOR-dependent autophagy. Biomol Ther 26(4):389\u2013398. https:\/\/doi.org\/10.4062\/biomolther.2017.071","journal-title":"Biomol Ther"},{"key":"2939_CR269","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fpls.2016.00197","volume":"7","author":"N Zhang","year":"2016","unstructured":"Zhang N, Sun Q, Li H, Li X, Cao Y, Zhang H, Guo Y-D (2016) Melatonin improved anthocyanin accumulation by regulating gene expressions and resulted in high reactive oxygen species scavenging capacity in cabbage. Front Plant Sci 7:197. https:\/\/doi.org\/10.3389\/fpls.2016.00197","journal-title":"Front Plant Sci"},{"issue":"7","key":"2939_CR270","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0273-8","volume":"51","author":"L Zhang","year":"2019","unstructured":"Zhang L, Li F, Su X, Li Y, Wang Y, Fang R, Guo Y, Jin T, Shan H, Zhao X, Yang R, Shan H, Liang H (2019) Melatonin prevents lung injury by regulating apelin 13 to improve mitochondrial dysfunction. Exp Mol Med 51(7):1\u201312. https:\/\/doi.org\/10.1038\/s12276-019-0273-8","journal-title":"Exp Mol Med"},{"key":"2939_CR271","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fncel.2018.00306","volume":"12","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang J, You Z (2018) Switching of the microglial activation phenotype is a possible treatment for depression disorder. Front Cell Neurosci 12:306. https:\/\/doi.org\/10.3389\/fncel.2018.00306","journal-title":"Front Cell Neurosci"},{"key":"2939_CR272","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.2147\/JIR.S317672","volume":"14","author":"R Zheng","year":"2021","unstructured":"Zheng R, Ruan Y, Yan Y, Lin Z, Xue N, Yan Y, Tian J, Yin X, Pu J, Zhang B (2021) Melatonin attenuates neuroinflammation by down-regulating NLRP3 inflammasome via a SIRT1-dependent pathway in MPTP-induced models of parkinson\u2019s disease. J Inflamm Res 14:3063\u20133075. https:\/\/doi.org\/10.2147\/JIR.S317672","journal-title":"J Inflamm Res"},{"issue":"2","key":"2939_CR273","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1600-079X.2004.00136.x","volume":"37","author":"LQ Zhu","year":"2004","unstructured":"Zhu LQ, Wang SH, Ling ZQ, Wang DL, Wang JZ (2004) Effect of inhibiting melatonin biosynthesis on spatial memory retention and tau phosphorylation in rat. J Pine Res 37(2):71\u201377. https:\/\/doi.org\/10.1111\/j.1600-079X.2004.00136.x","journal-title":"J Pine Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02939-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02939-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02939-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T04:28:05Z","timestamp":1716352085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02939-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":273,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2939"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02939-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Authors approve for submitting the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}